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The aim of the study was to design an upper body phantom to mimic the movement of the 
lesion inside the lungs during a breathing cycle.  Phantom design included an assessment of 
the motion observed for lung lesions, identification of suitable phantom materials as well as 
design of a motorized arm to mimic the movements observed inside the lung area of the 
phantom. 
Introduction: 
Expansion margins are added to clinical target volumes contoured by Oncologists in order to 
safeguard against under- or over-treatment of the target volume.  They are designed to account 
for errors during setup, inaccuracies on the linear accelerator, and movement of targets inside 
the patient.  If the margins are too small, there is a risk that the lesion/target may not receive 
the necessary dose, due to being partially missed.  On the other hand, if the margins are too 
wide, the lesion will be covered, but normal tissue may receive unnecessary dose, resulting in 
additional side effects to the patient.  Assessment of the impact of these margins is not possible 
in a static phantom and the availability of a low-cost motorized phantom would assist in the 
validation of these margins. 
Method: 
Previously treated patients’ 4D CT scanning data were used to quantify the amount of 
movement seen for lesions within the lung.  A phantom was then designed and built in an 
attempt to mimic both patient anatomy and movement.  Materials were identified to replicate 
anatomical shape and densities of various organs in the thorax, as seen on CT scan data.  Two 
treatment planning systems (Monaco, (Elekta) and Eclipse (Varian)) were used to determine 
the dosimetric characteristics of the materials.  This was compared to actual dose as delivered 
by a linear accelerator (Elekta Synergy). 
Results: 
Paths were calculated from the breathing cycles during the 4D-CT scan sets and templates 
designed to mimic these movements.  A thorax phantom was built with the appropriate 
materials suitable and matched densities to replicate a human thorax.  Comparing transmission 
for these materials on a linear accelerator for 6MV and 10MV energy, the deviation from 
planned versus measured dose varied between 1.67% to 3.32% and 0.45% to 2.30%, 
respectively for the silicon material and between 0.77% to 3.22% and 0.17% to 2.57% for the 




The measurements done on the linear accelerator matched closely with the calculated values 
on the treatment planning system for transmission through the materials in the customised 
phantom. 
Various proposals were put forward to mimic the movement of the targets within the lung 
regions.  However, it was not possible to manufacture a mechanically based working model 
due to the small movements observed (<5mm).  It is recommended that a robotic solution be 
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Today lung cancer is still a deadly disease, but the survival rate of patients is increasing. The 
overall quality of life can also be improved. Although surgery for lung cancer patients is an 
option, the complications and risks involved in surgery are factors that still need to be 
considered. Other non-invasive procedures then become far more attractive, for example 
radiotherapy and, more specifically, modern specialised techniques such as Stereotactic Body 
Radiotherapy (SBRT). 
 
The treatment of lung cancer with radiotherapy has always been a controversial topic due to 
highly inhomogeneous densities that need to be considered when calculating dose in these 
areas. Extreme caution should be taken to select the correct dose algorithms used in a Treatment 
Planning System (TPS). Another concern is movement during breathing, or the respiratory 
cycle of a patient. Depending on the location and size of the lesion in the lung, the motion can 
differ quite significantly. To accurately treat only this lesion and minimise dose exposure to 
the surrounding lung and organs at risk (OAR), it becomes difficult and complex to perform 
this type of treatment successfully. 
 
Margins are to safeguard against under- or over-treatment of the target volume that the 
oncologist has drawn in. They are designed to account for errors during setup, inaccuracies on 
the linear accelerator, and movement of targets inside the patient. If the margins are too small, 
there is a risk that the lesion/target may not receive the necessary dose, due to being partially 
missed. On the other hand, if the margins are too wide, the lesion will be covered, but normal 
tissue may receive unnecessary dose, resulting in additional side effects for the patient. 
 
Previously treated patients’ 4D scanning data will be used to quantify the amount of movement 
seen for the lesions within the lung. This will be done by evaluating and quantifying the 
movement of the targets as drawn in for the different 4D-CT scan sets. 
 
The impact of these increased or decreased margins can be evaluated on the treatment planning 
system to determine the radiobiological impact of the margin choices. It will therefore be 
possible to determine whether the margins used in clinical practices are optimal or 
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individualised, or patient specific margins can be used as recommended. This can be dedicated 
to a future project from this study. 
 
Due to these main risk factors for lung SBRT, the aim of the study is to design an upper body 
phantom to mimic the movement of the lesion inside the lungs during a breathing cycle. This 
phantom can then be used to test the impact of different radiotherapy treatment margins used 
in clinical practice by irradiating the targets on the linear accelerator, while the phantom and 
target mimic the Clinical Target Volume (CTV) or lesion motion. 
 
The aim of this study is to: 
• Determine the movement seen in previously treated patients from the 4D CT scan sets 
and used during SBRT treatment; 
• Design a thorax phantom to mimic tissue characteristics and internal motion of the 
CTV; 
• Compare the customised built phantom in terms of tissue characteristics applicable 
from the Treatment Planning System (TPS) and on the linear accelerator. 
 
Due to the retrospective patient data that will be used on the phantom, the following is in place 
for ethical consideration: 
• Consent forms from treatment site to use patient data and equipment; 
• Ethical application; 
• Patient consent form template. 
 
This study is a medical review study and will not influence clinical decision making or 
treatment in any way. 
 
Figure 1.1 is a flowchart which outlines the workflow of this study and the design and build of 












•Consent to use patient data retrospectively
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•Retrospective data from 4D scan
•Extract breathing cycle
•Delineate CTV on all phases of 4D scan
•Obtain coordinates (centre of CTV) for each phase
•Plot path of breathing cycle
Data Collection
•Current epidemiological status and available treatment 
techniques for primary lung tumours and metastatic lung 
disease
•Target volumes and expansion margins for lung lesions
•Motion of lung tumours
•BED, EUD, DVH risk maps
•Acquisition of target volumes





2 Literature Review 
 
2.1 Current status 
Today, early detection of cancer, new effective treatment options and improved clinical follow-
up after treatment have resulted in the number of cancer survivors increasing world-wide. Even 
where cancer is not cured, nowadays after diagnosis patients survive for longer periods than 
before (American Cancer Society Infographics, 2013). However, the outcome of radiotherapy 
is still lesion and site dependent. 
 
Historically, inoperable stage 1 lung cancer has been a diagnosis with limited treatment options 
(R. D. Timmerman, 2009). Patients with stage 1 lung cancer are often medically unfit to 
undergo anaesthetics and as a result surgical removal of their tumours may not be possible. 
Even if they are fit to undergo the surgery, the post recovery period is a risk to these patients 
due to general frailty and other comorbidities (Buyyounouski et al., 2010). Traditional 
radiotherapy approaches based on either 3D conformal techniques or observation without 
specific cancer therapy (watch and wait approach), resulted in poor tumour control and survival 
rates. Primary tumour control for medically inoperable patients with early stage lung cancer is 
30% to 40%. A high mortality rate (20% to 35% survival rate) is seen with the traditional 
management of this group of patients (R. Timmerman, 2010). The availability of SBRT can 
change the prognosis of this group of patients. 
 
Stereotactic Body Radiotherapy is a technique where highly focused radiation fields are aimed 
with very high precision at small target areas in the body of a patient.  ‘Precision’ refers to 
agreement between repeated independent measurement results under specific conditions that 
include, but are not limited to, dosimetric and geometric accuracy.  The term ‘accuracy’ 
describes the closeness of agreement between a result and the true value.  The accuracy is 
accomplished by combining imaging, simulation, treatment planning and delivery thereof into 
all phases of the treatment process  (Benedict et al., 2010).  This form of radiotherapy treatment 
requires a high level of confidence in terms of the accuracy of the overall treatment delivery 
process  (Benedict et al., 2010).  
 
Internationally, SBRT is now considered a well-established treatment option for inoperable 
early stage lung cancer with two-year local control rates ranging from 80% to 97% (Modh, 
2014).  Due to the small fields used during treatment, combined with high geometric precision 
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during treatment delivery, dose escalation is possible without compromising normal tissue.  
Although these tumours are typically close to organs at risk (OAR), the rapid dose fall-off 
inherent in this technique minimises doses to these structures.  This is achieved by dose 
prescriptions in SBRT that are specified at lower isodoses (e.g. 80% or 90% isodose) and with 
no or small margins for beam penumbra at the target edge.  This increases dose heterogeneity 
within the target compared to conventional therapy.  It has been hypothesised that the radio 
resistant hypoxic cells are located in the central part of the tumour and dose heterogeneity hot 
spots within the target may be acceptable and possibly even an advantage (Benedict et al., 
2010).  
 
Literature (D. R. Timmerman, 2014) indicates an increase in five-year survival outcomes from 
ten percent (10%) to thirty percent (30%) reported for 3D Conformal Radiotherapy (3D-CRT) 
(DE, 1992; Sibley, 1998), to 40% five year survival for patients receiving SBRT (R. 
Timmerman, 2014).  This is according to an update of RTOG 0236 published in 2010, where 
previously the original document of RTOG 0236 indicated only a three-year survival (R. D. 
Timmerman, 2009).  This technique can also be used for patients refusing surgery as well as 
for metastatic disease, e.g. spine, brain, liver and prostate (Benedict et al., 2010; Buyyounouski 
et al., 2010). 
 
The technique is technically difficult to implement, however, and various aspects need to be 
investigated and validated to allow for safe clinical use in the local context.  This study focuses 
on SRS techniques applicable to early stage lung cancer and metastatic lung cancer patients 
only. 
 
2.2 Classification of target volumes 
2.2.1 Volumes and margins 
Treatment delivery is dependent on volume and dose and these parameters need to be specified 
for different purposes such as prescription, recording and reporting.  Universally accepted 
terminology is important to ensure a common language when reporting results from different 
centres.  It is important, therefore, to define the volumes to be treated to the prescribed dose in 
a clear and concise way, irrespective of the treatment technique used.  This leads to concepts 
such as Gross Tumour Volume (GTV), Clinical Target Volume (CTV) and Planning Target 




First, to accurately define these different volumes for the purpose of dose escalation, a close 
relationship is needed between position of volumes and organs in the patient, and position and 
orientation of beams used during imaging and treatment.  This can be achieved by means of 
three coordinate systems, namely one within the patient, one related to the imaging unit and 
one related to the treatment unit.  To link these three coordinate systems, anatomical reference 
points or alignment marks are used to relate to the position of the volumes or tissue in the 
patient.  These are then again linked to the coordinate systems of the imaging and treatment 
machines since the reference points or alignment marks can be defined in both patient and 
machine coordinates (ICRU 62).   
 
Figure 2.1:  A suggested set of coordinate systems 
A suggested set of coordinate systems 
Cp – related to patient – internal reference point 
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CI – related to imaging unit – CT Scanner information 
CR – related to radiation therapy unit – external reference point. 
("International Commission on Radiation Units and Measurements.  Prescribing, recording, 
and reporting photon beam therapy (supplement to ICRU report 50). ICRU report 62. 
Bethesda, MD," 1999) 
 
The reference points can be either internal or external and form the basis to establish the patient 
coordinate system as well as assist with reproducible alignment of the patient for imaging and 
treatment.  Anatomical landmarks such as bony anatomy may be used for localisation of the 
GTV or CTV and accurate set-up at the imaging and treatment unit.  These landmarks are 
referred to as internal reference points.  External reference points are palpable or visible points 
on the surface of either the patient or the immobilisation device in use that fits closely to the 
external body of the patient.  The coordinate system for the patient is based on these internal 
and external reference points for orientation of the system and alignment of the patient (ICRU 
62).  
 
Coordinate systems related to imaging and treatment units are defined with respect to the 
gantry, collimators, radiation and light beams, laser alignment beams and couch-top system 
(ICRU 62).   
 
The GTV or Gross Tumour Volume is the gross palpable visible/demonstrable extent and 
location of the malignant growth.  ("International Commission on Radiation Units and 
Measurements.  Prescribing, recording, and reporting photon beam therapy (supplement to 
ICRU report 50). ICRU report 62. Bethesda, MD," 1999) 
 
The tissue volume that contains a GTV and/or demonstrable tumour and/or areas of suspected 
subclinical microscopic malignant disease is defined as the Clinical Target Volume (CTV).  
("International Commission on Radiation Units and Measurements.  Prescribing, recording, 
and reporting photon beam therapy (supplement to ICRU report 50). ICRU report 62. Bethesda, 
MD," 1999)  CTV is referred to as the volume that should receive the prescribed dose and be 
treated adequately to achieve cure or palliation; the aim of therapy.   
 
Unfortunately, the CTV may not be exactly in the same position on a day by day basis as a 
result of geometric uncertainties.  These geometric uncertainties may come from three sources 
(ICRU 62):   
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1. Patient set-up variation; 
2. Organ motion and deformation; and 
3. Machine related errors. 
 
In 3D Conformal Radiotherapy Treatment (3D-CRT) the CTV should be expanded with a 3D 
margin to create the Planning Target Volume (PTV) to compensate for the geometric 
uncertainties defined above.  The planned dose to the PTV will then be representative of the 
real dose to the CTV and the heterogeneity in dose delivery should be kept within 95% to 107% 
for 3D-CRT (Stroom & Heijmen, 2002). 
 
2.2.2 Motion in lung lesions 
SBRT is now emerging as a state-of-the-art treatment for lung cancer patients and may even 
challenge instances where operable surgery is an option (Baumann et al., 2009).  Due to the 
high doses delivered to the target, the margins associated with these treatments are crucial (R. 
W. Underberg et al., 2004).  Higher radiation dose is associated with better failure-free and 
overall survival. However healthy lung tissue, the heart and oesophagus are dose-limiting 
organs.  Increasing the dose without reducing the irradiated volume results in an increase of 
the mean lung dose which leads to higher probability of radiation pneumonitis.  This also brings 
forth an increase in dose to OARs  (Marks et al., 2010).  To enable safe dose escalation, tumour 
volumes (TV) and the associated irradiated volumes of normal tissue should be minimised 
(Caldwell, 2003; Wolthaus et al., 2008) 
 
To compensate for expected physiological movements and changes in shape, size and position 
of the CTV during treatment, a margin must be added.  This is referred to as the Internal Margin 
(IM).  The IM is intended to compensate for all movements and variations in position, size and 
shape of organs and surrounding tissue adjacent to the CTV.  This is an asymmetrical expansion 
of the CTV, therefore should be expanded with a 3D margin.  These internal variations can be 
due to respiration, bladder filling, rectal filling, heartbeat, bowel movements, to name but a 
few.  They either cannot be controlled or have limited control (in terms of, for example ‘bladder 
fill protocols’) and do not depend on external uncertainty in beam geometry but could be 
influenced by variation in day-to-day patient setup (ICRU 62).  This volume, after expansion 
with the 3D margin, IM, is defined as the Internal Target Volume (ITV), which is considered 
as the intermediate volume (Stroom & Heijmen, 2002).  The main contributors to this margin 
in thoracic tumours are respiratory and cardiovascular motions.  The degree and direction of 
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movements are dependent on the location of the tumour in the lung and can be visualised where 
4DCT are available.  Tumours closer to the diaphragm and heart will have bigger movement 
than those fixated to a structure or OAR  (Caldwell, 2003). 
Variations or uncertainties in the reproducibility of patient positioning and inaccuracies in 
alignment of beam positioning during planning and throughout treatment are accounted for 
with a set-up margin (SM) (Berthelsen, 2007).  Uncertainties may vary on different anatomical 
directions and the margins then depend on selection of beam geometries.  Factors such as 
variations in patient positioning, lack of reproducibility of equipment (for example sagging of 
gantry, etc.) and human factors can influence these inaccuracies.  These may even vary from 
machine to machine (Berthelsen, 2007).  With the use of a 2D set-up margin (SM) it can 
become quite complicated to incorporate this margin with awkward gantry and/or couch angles.  
Instead the ITV is expanded with a 3D SM to arrive at the PTV then to be used for plan design 




Figure 2.2:  Description of margins 
(Berthelsen, 2007) 
Figure 2.2 depicts three different clinical scenarios.  In scenario A a margin is added to take 
into account potential subclinical invasion around the GTV.  This margin and the GTV is 
defined as the CTV.  In External Beam Radiation Therapy (EBRT) all uncertainties and 
geometrical variations need to be considered to ensure that the CTV receives the prescribed 
dose.  This is done with appropriate/additional margins.  As previously discussed for variations 
in position and/or shape and size of the CTV, an IM is added which creates the ITV.  The SM 
accounts for variations and/or uncertainties in patient-beam positioning.  Therefore 




This linear addition of margins can lead to an excessively large PTV that will include OAR 
and normal tissue and is not compatible with tolerance doses as depicted in Scenario A 
(Berthelsen, 2007).  When calculating the SM to determine an appropriate PTV, all deviations 
from the planned irradiation geometry during a treatment session should be taken into account.  
These can be due to random or systematic errors. Random errors are defined as fraction-to-
fraction variations around the mean deviation in the measurement/treatment, whereas 
systematic errors occur when the mean irradiation geometry in the fractionated treatment 
differs/deviates from the geometry in the treatment plan (Stroom & Heijmen, 2002). 
 
All these errors cannot be added linearly as this will lead to an excessively large PTV and 
would be incompatible with the tolerances of surrounding tissues, as mentioned above. 





2)  (Stroom & Heijmen, 2002). 
 
Two separate coordinate systems and reference points are used in clinical practice and that was 
the argument to introduce ITV and SM.  Both internal movement and set-up variation are 
measured with respect to bony anatomy.  The effect of organ motion and set-up error (similar 
size and direction) is basically equal on the dose in the CTV.  It is therefore assumed that the 
internal and external uncertainties are uncorrelated.  These uncertainties are characterized by 
the overall distribution of systematic errors (set-up) ⅀tot = √(⅀int
2 + ⅀ext
2 ), and random errors 
(internal movement) σtot = √(σint
2 + σext
2 ).  Any combination of ⅀int and ⅀ext are equivalent 
with respect to the planning margin.  The important parameters for calculating margins are ⅀tot 
and σtot, which reduces the need for separation of ITV and SM in this scenario.  This leads to a 
standard deviation, SDtot = √(⅀
2 + σ2), which then should be used for margin calculation.  
(Stroom & Heijmen, 2002) 
 
This adaption leads to scenario B in the figure above  (Berthelsen, 2007). 
 
In the majority of cases, a ‘global’ safety margin is accepted, but in some cases the close 
proximity of an OAR reduces the width of this safety margin.  This is shown in scenario C.  
Also, to keep in mind is that the subclinical invasion may decrease with distance from the GTV, 
which could depict a reduction in margin and still be compatible with chances for cure.  Safety 
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margins vary with the angle at which one looks at the PTV.  If an adequate dose cannot be 
given to the whole GTV, the treatment aim shifts from radical to palliative (Berthelsen, 2007). 
 
These margins (IM+SM) are the defining margins to account for the combined effect of errors 
during setup and inaccuracies on the linear accelerator, as well as movement of targets inside 
the patient, as described above (IRCU 62). The impact of the target movement as well as the 
inaccuracies in treatment delivery need to be defined for the specific patient and the specific 
clinic where the radiation is being delivered to accurately calculate the required margins. 
 
Depending on the clinical situation, patient condition and site of CTV and the chosen treatment 
technique, as shown below in Figure 2.3, the PTV could be very similar to the CTV (small skin 
lesions) or much larger (lung tumours). 
 
 
Figure 2.3:  Diagram of different treatment-planning concepts 
(Wolthaus et al., 2008) 
Conventional free-breathing; internal target volume (ITV); gating at exhale and mid-position. 




Static CT is only a ‘snapshot’ of the mobile CTV which can be some distance away from the 
mean position of the moving tumour.  The symmetric ‘population based’ margins used 
historically may introduce systematic errors or even geographic miss of the tumour in the plan 
(Caldwell, 2003).  Individualised margins are now proposed as more appropriate for lung 
tumours as opposed to the historic standard ‘population based’ margins (R. W. Underberg et 
al., 2004). 
 
As mentioned before, stereotactic radiotherapy relies heavily on tight margins and steep dose 
gradients to reduce dose impact on organs at risk.  Although the definitions of volumes as 
mentioned in above discussions are still applicable to stereotactic radiotherapy, the methods 
used to generate the various volumes in stereotactic radiosurgery can differ from those applied 
to 3D conventional radiotherapy.  For example, the calculation of the set-up margin for PTV 
in a single fraction treatment with steep dose gradient may not be relevant to the common 
formalism used (IRCU 62).   
In lung tumours located in the lower lung, IM due to respiratory motion can overshadow the 
required SM.   
• When the patient breathes freely during the entire process of treatment, tumour motion 
needs to be quantified for treatment planning.  Contouring on co-registered 
prospectively binned inspiratory and expiratory 3D CT or on a maximum-intensity 
projection (MIP) CT scan (from a retrospectively binned 4D CT dataset) can be used 
to determine the ITV for tumours associated with respiratory motion.   
• With breath hold or respiratory gating, the IM will need to account for uncertainties 
in reproducing the breath hold and residual motion.   
• During direct tumour chasing or tumour tracking the IM will need to account for 
variations in the correlation of internal and external markers or fiducials or movement 
of the tumour in relation to the implanted fiducials.   
• Deformation and rotation of the tumour are included in the IM, but these components 
can be very small.   
 
It should always be remembered that IM and SM are tools to ensure coverage of the CTV.   
(IRCU 62).  
 
As radiotherapy treatment machine technology improves in terms of mechanics and quality 
assurance, target contouring or delineation of volumes account for a larger part of the treatment 
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uncertainties.  Identifying normal tissue as tumour and vice versa can lead to significant impact 
on radiobiological doses to the patient with regard to either under dosing of the tumour when 
the tumour is contoured as normal tissue and overdosing of normal tissue if normal tissue was 
identified as tumour.  Adding margins to compensate for these possible variations in target 
contouring is not the solution.  Establishing appropriate target volumes must be evaluated on a 
technique-specific basis taking into account the radiobiological response of both the specific 
tumour as well as the critical structures in the immediate vicinity (IRCU 62).  
 
2.2.3 Acquisition of target volumes 
In most RT treatment planning departments CT scans are acquired during quiet respiration.  
The assumption is made that during daily treatments, the position of the target will correspond 
to these CT scans.  However, the short sampling times of modern CT scanners relative to the 
breathing cycle may result in an inaccurate 3D target volume generated for treatment planning 
purposes.  This happens if the breathing cycle captured during the CT scanning acquisition 
does not correspond to the breathing cycle during treatment (Lagerwaard et al., 2001). 
 
Approaches available to determine more accurate target volumes and individualised margins 
are ‘slow’ CT scans (Lagerwaard et al., 2001), deep inspiration and breath-hold CT scans 
(Hanley et al., 1999) or 4D or respiration-correlated CT scans (R. W. Underberg et al., 2004). 
 
These technologies/approaches will be discussed in more detail in Section 2.4. 
 
2.3 Radiobiological dose response modelling 
Achieving local tumour control is directly related to the radiation dose that can be delivered to 
the cancer cells, but is limited by the dose that can be tolerated by the surrounding normal 
tissue and critical structures or OARs close to the tumour.  For some structures such as lungs, 
the dose that can be tolerated depends on the volume of normal tissue (lung) that is included in 
the treatment field.  With advanced 3D conformal techniques, careful target definition and 
delivery allows dose escalation due to the fact that the volume of normal tissue included in the 
field can be decreased through careful planning (Barnes et al., 2001). Radiobiological models 
allow quantification of the risk of developing side effects based on the doses associated with a 
specific plan.  For example, development of grade 2 or higher pneumonitis has been shown to 
be dependent on the percentage of total lung receiving 20Gy in 3D conformal therapy (V20).  
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A tight margin is therefore desirable to reduce the dose to surrounding tissue but must not result 
in under dosing the tumour via geographic miss (Barnes et al., 2001).  Radiobiological 
modelling or dose-response modelling, therefore, can be used to determine appropriate margins 
as discussed above (Stroom & Heijmen, 2002). 
 






5. Follow-up time 
6. Estimated risk of the endpoint occurring within the follow-up time.  (Asbell, Grimm, 
Xue, Chew, & LaCouture, 2016). 
 
In 3D conformal radiotherapy these dose tolerance limits evolved from Emami (Emami, 1991) 
to Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) which is 
currently considered the most accurate method to assess normal tissue complication probability 
(NTCP) for conventional fractionation (Marks et al., 2010).  In terms of Stereotactic Ablative 
Body radiotherapy (SABR) or Stereotactic Body Radiotherapy (SBRT) dose-tolerance 
guidelines are extremely rare and published data sparsely available (Asbell et al., 2016). 
 
Three studies of SBRT patients with early stage lung cancer who received Biological Effective 
Doses (BED) of 100Gy10 or more, where Gyx denotes x=α/β in the linear quadratic model 
reported five-year survival rates ranging from 30% to 83%.  This demonstrates that significant 
local control and survival advantage can be achieved when a BED of 100Gy10 or more is 
delivered (Srivastava, 2013). 
 
The Biological Effective Dose (BED) is a characteristic dose value that facilitates comparisons 
between the effects of different dose-fractionation schemes.  The definition of BED is 
expressed as the total dose delivered in an infinite number of infinitesimal small dose fractions 
that has the same biologic effect as the dose-fractionation scheme in question.  Completed 





Conversion of dose to BEDs has its own challenges as there are so many methods to convert 
these doses (Asbell et al., 2016). 
 
One method of calculating BED makes use of the Linear Quadratic theory.  In this case the 
numerical value of BED is expressed in terms of the α and β values of the Linear Quadratic 
(LQ) model: 
 
Natural log of S (surviving proportion) 
 
lnS = -α*d – β*d2  (LQ equation) 
 
where d is the dose and α and β are expansion parameters; α is the slope of the survival curve 
at the limit d → 0, and β is the parameter determining the relative contribution from the 
quadratic component.  (Park et al., 2008) 
 
BED = D*(1 + d/α/β ) 
 
where D is the total dose delivered in n fractions of size d  (Park et al., 2008). 
 
Figure 2.4:  Actual Biological Effective Dose (BED) is over-estimated when expressed 
through the linear quadratic (LG) model parameters 
(Park et al., 2008) 
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Actual BED is over-estimated when expressed through the LQ model parameters. 
 
This formulation of the LQ model is applicable to dose ranges below the commonly used 
ablative doses in SBRT.  This model predicts a continuous downward bending curve in the 
high-dose region as depicted in Figure 2.4.  An overestimation of radiation is therefore 
predicted in this LQ model in the high-dose range (Park et al., 2008). 
 
An alternative description of clonogenic survival as a function of radiation dose is based on the 
multitarget model.  This model is valuable in the high-dose range as shown in Figure 2.5.  A 
universal survival curve model was constructed from the LQ model survival curve for the low-
dose range and the multitarget model asymptote for high-dose range (Park et al., 2008). 
 
 
Figure 2.5:  The dose range at which the LQ and multitarget model is valid on the 
Universal Survival Curve (USC) 
(Park et al., 2008) 
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The dose range at which the LQ and multitarget model is valid on the USC.  Below transition 
dose DT, USC is identical to LQ and above DT, USC is identical with terminal linear portion 
of multitarget model. 
 
With conventional dose tolerance limits, Emami’s method organised the same percentage 
volumes (⅓, ⅔,3/3) for most critical structures throughout the body for these limits and 
partitioned/divided it into two risk levels (5% and 50%).  Emami’s dose tolerance limit table 
therefore consisted of six values for each critical structure, three values for low risk (5%) and 
three values for high risk (50%) doses by volume.  See part of Table 2.1 below  (Emami, 1991). 
 
 
Table 2.1:  Normal tissue tolerance to therapeutic irradiation 
(Emami, 1991) 
 
For SBRT a similar unified format was needed.  Because of the strong dependency on 
fractionation and the fact that the volumes are vastly different from those seen in conventional 
fractionation for SBRT, five rows were needed according to number of fractions (fraction 1-
5).  However, the true statistical risk is still unknown for most published SBRT dose tolerance 




An additional parameter that needs to be included from the most common published SBRT 
dose tolerance limits is the maximum point dose (i.e. zero volume).  For the ablative doses of 
SBRT only small volumes are tolerable to these doses (Srivastava, 2013).  Grimm et al. (2011) 
performed an extensive review of literature to compare dose limits utilised and reported in 
existing publications. This was an initial step closer to the goal of having a comprehensive set 
of SBRT normal organ dose tolerance limits.  From this extensive review a similar unified 
format could be established (Srivastava, 2013). 
 
 
Table 2.2:  Low and High Risk Limits for aortic toxicity 
(Srivastava, 2013) 
 
As described in the paragraph and shown in Table 2.2, the unified dose tolerance format for 
SBRT consists of five rows, one for each fractionation (1-5); two risk groups (columns) namely 
one for low-risk and one for high-risk; and then five columns within each of these risk groups, 
for each of the five dose-descriptor points or volume vs dose limits.  These include 50% 
volume, 10% volume, the two most common cubic centimetre (cc) absolute volumes (Grimm, 
2011), of which the one is 1cc and the maximum point dose (Srivastava, 2013). 
 






5. Follow-up time; 
6. Estimated risk of the endpoint occurring within the follow-up time.   




To keep this relationship between dose tolerance limits and their respective risks as simple as 
possible, simple graphs of the dose tolerance limits as a function of the number of fractions 
were made.  This led to the creation of the dose-volume histogram (DVH) Risk Map (Asbell 
et al., 2016; Srivastava, 2013). 
 
In the Dose-Volume Histogram (DVH) Risk Map only pure physical dose is used to plot these 
limits on a linear scale.  The Timmerman 2008 limits (R. D. Timmerman, 2008) are related by 
straight lines  (Asbell et al., 2016).  From the universal survival curve (USC) this potential 
linear expression of BED at high dose per fraction can be seen and was explained in the above 
paragraphs.  The USC is one of the many models that have been proposed as alternatives to the 
LQ model for biological equivalence (Asbell et al., 2016). 
 
The DVH Risk Map consists of dose on the y-axis, each subplot is for a specific volume, and 
the x-axis, the number of fractions for each subplot.  Inverse power law, effective volume (Veff), 
effective dose (Deff) or Equivalent Uniform Dose (EUD) are some of the dose-volume metrics 
that combine dose and volume. A dose-tolerance limit can be specified by any of these metrics 




Figure 2.6:  Simplified DVH risk map for Spinal Cord 
(Asbell et al., 2016) 
 
DVH Risk Map for spinal cord, Dmax limits for 1, 3 and 5 fractions (R. D. Timmerman, 2008).  





Figure 2.7:  DVH risk map for rib maximum point dose, Dmax 






Figure 2.8:  DVH risk map 
(Asbell et al., 2016) 







Figure 2.9:  Full DVH risk map for ribs 
(Asbell et al., 2016) 
 
In SBRT, absolute volume is more important, particularly small absolute volumes like 1cc or 
0.1cc.  In addition to D50%, D10% and Dmax another two absolute volumes are provided for DVH 
Risk Maps dose-tolerance limits depending and chosen specific to each anatomical structure  
(Asbell et al., 2016). 
 
Final treatment volumes are highly dependent on margins added to the CTV, and any increase 
in margin will increase volume of normal tissue receiving radiation.  The likelihood of 
treatment-related toxicity can therefore be limited by defining individualised target volumes 
more accurately, especially when working with highly mobile tumours (R. W. Underberg et 
al., 2004). Lung volume in the high-dose region is a dose-limiting factor for lung carcinoma 
treatments.  Reduction in treatment margins could, in principle, allow for increased dose to the 




2.4 Acquisition techniques 
 
2.4.1 Slow CT scans 
‘Slow’ CT scans are performed at a rotation of 4s (Lagerwaard et al., 2001), whereas the latest 
technology has a rotation time of 0.28s ("Siemens Somatom,").  A single ‘slow’ rotation should 
correlate to one breathing cycle of the patient to include all target motion during a respiratory 
cycle.  A ‘slow’ CT scan is limited to the region of interest and therefore the time required to 
complete a scan is comparable to that of a complete planning CT scan.  The radiation exposure 
arising from this ‘slow’ scan was calculated between 20% and 25% of that of a standard 
planning CT scan (Lagerwaard et al., 2001). 
 
In another study it was also concluded that although the ‘slow’ CT scan reduces the ITV, 
delineation of the lesion becomes much more difficult.  This is due to the blurring or ‘smeared 
out’ effect of the lesion at the edges.  Another concern is when the lesion is in close proximity 
of OAR’s, definite edges are hard to recognise and is sometimes difficult to distinguish tumour 
from infiltrate.  In this study the CTV coverage analysis suggests an underdosage should the 
‘slow’ CT scan be used for delineation of the lesion.  (Bosmans et al., 2006) 
 
2.4.2 Deep inspiration breath-hold technique 
Deep inspiration breath-hold (DIBH) reduces lung density by increasing lung volume, and it 
immobilises lung tumours and therefore allows reduction in margins.  The reduced lung density 
relative to the tumour in the high-dose region can reduce the amount of normal lung tissue 
irradiated, thus reducing morbidity (Hanley et al., 1999).  With high energy photon beams 
secondary electrons produced by Compton interaction of the photons (Ekstrand & Barnes, 
1990) set in motion are capable of penetrating to an average depth characterised by the 
measured depth of maximum dose for these beams.  Lateral scatter of electrons out of the beam 
is known to reduce dose near the beam edge for all megavoltage photon beams (White, 
Zwicker, & Huang, 1996).  This is because the electrons scatter laterally as well as moving in 
a forward direction with the beam; therefore electrons travel outside the geometric boundaries 
of the radiation field (Ekstrand & Barnes, 1990).  The reduced lung density in the beam path 
further compromises lateral electron equilibrium by allowing even greater electron travel.  This 
could result in loss of electronic equilibrium along the central axis near the lung/soft tissue 
boundary (White et al., 1996).  This may result in an increase in penumbra and deterioration in 




Penumbra is defined as the rapid decrease of dose at the edge of the radiation beam.  This is 
usually defined as the distance or space between the 20% and 80% isodose lines of the central 
axis dose value.  There is a dramatic increase in penumbra with increased photon energy when 
density decreases.  A way to measure the lack of flatness in the beam is to determine the 
distance between the 50% and 90% dose levels.  This is then defined as the ‘beam fringe’ to 
distinguish it from beam penumbra.  The fringe is significant in the sense that it represents the 
minimal margin that is needed around the tumour to ensure that the tumour receives at least 
90% of the dose on the central axis (Ekstrand & Barnes, 1990).  The assumption can be made 
that increased penumbra is inversely proportional to density.  The DIBH technique could, on 
average, expect to increase the 50%-90% beam fringe by 1.5mm, which has little dosimetric 
significance compared to the margins applied for other treatment uncertainties, e.g. set-up and 
residual organ motion (Hanley et al., 1999). 
 
The technique involving coaching of the patient to ensure and reproduce deep inspiration level 
throughout planning and treatment delivery is called a DIBH technique which involves a 
modified version of the slow vital capacity (SVC) manoeuvre. 
 
 
Figure 2.10:  Modified SVC manoeuvre 
(Hanley et al., 1999) 
This DIBH manoeuvre begins with the patient in quiet respiration, followed by one slow deep 
inspiration and one deep expiration, then another slow deep inspiration to maximum level and 
then breath-hold.  A spirometer monitors the patient’s respiration level.  The patient breathes 
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through a mouthpiece, a nose-clip is used to prevent nose breathing.  The spirometer measures 
the volume of inhaled and exhaled air and is recorded as a function of time.  CT slices are 
acquired during the breath-hold period only.  The breath-hold scans are acquired using three to 
four segments of which each segment consist of 10 to 13 second breath-hold (Hanley et al., 
1999). 
 
These two properties, namely target immobilisation and expanded lung volume from the DIBH 
technique, can potentially be beneficial to lung carcinoma treatments and potentially allow for 
dose escalation (Hanley et al., 1999). 
 
2.4.3 4D CT scans 
With the use of 4D or respiration-correlated CT scans, this technique entails retrospective 
gating, the respiratory waveform is synchronously recorded during CT acquisition, and 
multiple CT slices are acquired at each table position for at least the duration of one full 
respiratory cycle.  This yields CT datasets for 10 phase bins of the respiratory cycle (R. W. 
Underberg et al., 2004). 
 
In a 4DCT scan, spatial and temporal information on shape and mobility are acquired 
synchronously in a single investigation.  The breathing pattern can be recorded either with a 
Real-time Positioning Management System (RPM) (Slotman, Lagerwaard, & Senan, 2006) or 
with the use of a Respiratory Gating System (Solutions). 
2.4.3.1 Real-time Positioning Management System (RPM) 
The respiratory breathing signals are recorded using infrared-reflecting markers on the upper 
abdomen of the patient during free breathing.  The markers are illuminated by infrared-emitting 
diodes surrounding a camera.  The motion of these markers is captured at a frequency of 25 
frames per second.  The respiratory signal is recorded in synchronisation with the x-ray ‘on’ 
signal from the CT scanner.  A single 4DCT scan is relatively simple and poses no problem for 
patients with poor pulmonary function.  Although the radiation exposure from a 4DCT scan is 
approximately six times higher than a conventional helical CT scan, the additional dose 
associated with the 4D scan can be justified with the smaller volumes generated from the 4DCT 
scan in comparison with the standard PTV (Slotman et al., 2006). 
2.4.3.2 Respiratory Gating System – Anzai 
There are two types of respiratory sensors available: 
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• Load Cell Sensor (Patient contact type); 
• Laser Sensor (Non-Patient contact type). 
 
The first sensor mentioned detects pressure by using strain gauge bridge circuit.  The pressure 
detecting part is used with a belt and the motion of the body surface (pressure change at the 
abdomen) is displayed as a respiratory waveform. 
The second sensor measures the reflection of laser light (infrared).  Laser light is spotted on 
the patient’s skin and the motion of the body surface (displacement of distance to the sensor) 
is displayed as a respiratory waveform  (Solutions). 
 
After the 4D datasets have been acquired, the datasets are sorted in 10 phase bins within the 
respiratory cycle.  Registration is made based on nearest neighbour criterion, where at each 
slice location the image is selected so that its phase is closest to each phase bin.  These 
volumetric datasets are a representation of the 10 phases of respiration (bins). 
 
Figure 2.11:  Overview of respiratory phase ‘bin’ generation from 4D CT data 
(R. W. Underberg et al., 2004) 
For this study, 4D CT data sets with the Anzai Respiratory Gating system with the Load Cell 





2.5 Commercially available motion phantoms 
Several radiotherapy motion phantoms are available commercially.  The QUASARTM 
Respiratory Motion Phantom is a programmable state-of-the-art breathing simulator for 




Figure 2.12:  Commercially available Quasar Phantom 
("Quasar Phantom,") 
The software application downloads patient respiratory waveforms to the phantom, simulating 
the breathing function.  The body of the phantom is made from acrylic with two openings with 
acrylic, cedar and hollow inserts available. 
 
This respiratory motion phantom is regularly used to simulate patient breathing patterns to 
check image quality and accuracy for 4D CBCT systems (Lee et al., 2015) and checking of 
consistency of contouring or delineation of volumes with the different contouring tools 
available across multiple treatment planning systems (Pogson et al., 2015).  One of the main 
aims of this phantom is to implement quality assurance of motion management in a 
radiotherapy department.  In an Australian Research Institute this phantom was modified to 
simulate more realistic patient motion by replacing the DC motor by a stepper motor.  A 
separate motion platform was also designed to accommodate a variety of surrogate marker 
systems and to allow reproducing motion in more directions.  This upgraded motion phantom 
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was found to be useful in terms of simulating patient motion and test patterns to aid in quality 
assurance of motion management.  (Dunn et al., 2012) 
 
RS-1500 Dynamic Dan breathable phantom from Oprax Medical International is a complex 
plastic simulation of a humanoid torso including lungs, ribcage/chest-wall bone, skin and sub-





Figure 2.13:  Dynamic Dan. Complex breathable phantom 
from Oprax Medical International 
("Dynamic Dan,") 




However, these phantoms are extremely expensive and therefore not cost effective or readily 
available in a third world country.  A non-commercial locally designed phantom was therefore 
investigated as an alternative to the high cost commercial phantoms. 
 
2.6 Customised dosimetry phantom 
A suitable phantom to mimic this movement and accurately determine if the margins are 
adequate or not, is extremely costly.  It is also not fulfilling the true aim to determine if certain 
margins are used correctly for a specific patient and location of a lesion in the lung (R. W. 
Underberg et al., 2004).  Different motion phantoms are on the market which include, but are 
not limited to, QUASARTM Respiratory Motion Phantom as shown and discussed previously.  
The phantom is made of acrylic, which is not tissue equivalent, especially when measuring in 
different mediums such as lung.  This is important for dosimetric considerations (Akhlaghi, 
Hakimabad, & Motavalli, 2015).  Although it can be set to different breathing cycles, bpm 
(breath per minute), the actual movement of the target within the lung is dependent on size and 
location in the lung (R. W. Underberg et al., 2004; Wolthaus et al., 2008).  For customised 
build phantoms, proper materials and densities must be found.  This includes matching on CT 
scans (relative electron density) (Steidl et al., 2012) as well as measurements on the linear 
accelerator with MV photon beams.   
 
As mentioned before, there are commercialised phantoms that mimic movement, but not as per 
original patient dataset.  By this statement it is meant that directly from the 4D CT scanner, the 
exact breathing cycle are not imported into the phantom, but a breathing cycle is mimicked.  
Movement differs in different sections of the lung, and in breathing cycles, which is dependent 
on each patient dataset (Wolthaus et al., 2008).  Trajectory of the tumour motion due to 
respiration can be determined from the 4D CT patient dataset.  The position of the tumour can 
be shown relative to phase zero of the 10 phases within the dataset, as reconstructed during the 
4D CT scan.  Data can be derived for left-right (LR), cranio-caudal (CC) and anterior-posterior 








From published data this is as follows: 
 
 Tumour Motion (mm) 
 LR CC AP 
Upper Thorax 1.7 (1.3) 3.7 (2.8) 3.1 (2.5) 
Lower Thorax 2.3 (1.3) 11.6 (4.8) 3.1 (2.0) 
Total 1.9 (1.3) 7.2 (5.5) 3.1 (2.3) 
Table 2.3:  Tumour in 3D for 45 patients (whole patient group) in position in thorax 
(Wolthaus et al., 2008) 
Values are mean (SD) 
 
Proper materials and their respective densities must be found to build a customised phantom 
that will fulfil one of the aims of this study: 
• Design a thorax phantom to mimic tissue characteristics and internal motion of the 
CTV. 
 
The physical properties of proposed tissue materials include: 
1. Electron density; 
2. Effective atomic number; 
3. CT number or average Hounsfield unit (HU).   
(Akhlaghi et al., 2015). 
 
As far as the density and thickness are concerned, before any dose calculation is done, the 
phantom will be scanned with a CT scanner and relative electron density curve will be taken 
into account to convert the Hounsfield units of a CT scan to electron densities that can be used 
in dose calculation algorithms.  Electron density (number of electrons per gram) ρe and 
effective atomic number Zeff is specified by the following equations: 
Equation  ρe = NA ⅀i (WiZi)/Ai 
 







where NA is Avogadro’s number, and Wi, Zi and Ai are the weight fraction, the atomic number 
and the atomic mass of each atom, respectively (Akhlaghi et al., 2015; J. Chang, Suh, & Lee, 
2010). 
 
For the outer shell, first aid mannequins were explored, which could be ideal, but the cost 
thereof was high.  Also, some of the mannequins have internal organs that would not suit our 
purpose.  Rubber or acrylic used as the outer shell from a mould is also a favourite material in 
customised phantoms (J. Chang et al., 2010; Steidl et al., 2012). 
 
The ribs’ composition or equivalent material is another challenge to overcome.  In some cases, 
commercial artificial skeletons made from polyvinyl carbonate (PVC) are used (Steidl et al., 
2012) or no skeleton or ribs were chosen. 
 
Dosages to normal lung tissue are critical in SBRT dose prescription and dose heterogeneity 
corrections are needed for accurate estimation of absorbed doses within and around irradiated 
thorax tissues.  Carefully selected materials are therefore necessary, but a lung substitute is 
more difficult to establish due to the low physical density  (K.-P. Chang, Hung, Chie, Shiau, & 
Huang, 2012).  Lung cavities are air in most cases, but lung phantom cavities are also filled 
with dampened sponges (J. Chang et al., 2010).  In a paper by Akhlaghi et al. (2015) the 
proposed lung equivalent materials were polyurethane foam and composition cork.  Reference 
lung material in a healthy adult lung has a physical density of 0.26g/cm3, effective atomic 
number (Zeff) of 3.43 and CT number between -950 and -750  (K.-P. Chang et al., 2012). 
 
Water is the standard to be used for soft tissue in literature for a phantom (Molineu et al., 2005).  
But, to waterproof and keep the water fresh is a challenge.  Another option is rubber, but then 
conversion of Hounsfield units of CT scan into water-equivalent path lengths must be 
considered (Steidl et al., 2012).  Gelatine gels can also be used as an alternative in phantoms 
for soft tissue, but the chemical and morphological conditions promote degradation of the gel 
and this is a limiting factor as it has a shelf life and needs to be kept at a certain 





2.7 Additive manufacturing technologies 
From the middle 1980s additive manufacturing technologies have benefitted many applications 
from faster processing of products without the need for specific tooling or dies.  In the area of 
biomedical devices, development has been slow due to stringent performance criteria and 
concerns related to reproducibility and part quality. Additive manufacturing (AM) technologies 
in bone tissue engineering has been growing rapidly in recent years and three-dimensional (3D) 
printing is becoming popular due to the ability to directly print porous scaffolds (structures) 
with designed shape, controlled chemistry and interconnected porosity (Bose, Vahabzadeh, & 
Bandyopadhyay, 2013). 
 
3D printing was developed in the 1990s at MIT, Cambridge and is a powder based freeform 
fabrication method (also known as solid free form fabrication (SFF) (Chia & Wu, 2015) in 
which using a regular ink-jet print-head, binders are printed onto loose powders in a powder 
bed.  3D printing, solid free form fabrication and rapid prototyping are different AM 
approaches for scaffold fabrication.  Fabrication of the scaffolds or complex 3D structures with 
tailored porosity is done from a CAD file.  A CAD file is an image file format and stands for 
Computer Aided Design (Bose et al., 2013).  The integration of CAD, advanced imaging 
techniques such as MRI and CT scans and rapid prototyping has improved or aided the 
advanced fabrication of such 3D objects (Chia & Wu, 2015).  The following commercially 
available AM techniques all create 3D scaffolds layer-by-layer (RP technology) (Peltola, 
Melchels, Grijpma, & Kellomäki, 2008) without any part specific tooling or dies: 
• 3D Printing; 
• Fused deposition modelling; 
• Selective laser sintering; 
• Stereolithography; 
• 3D plotting; 
• Various forms of direct writing.  (Bose et al., 2013). 
 
These AM techniques can be classified as: 
• Extrusion (deformation + solidification); 
• Polymerisation; 
• Laser-assisted sintering; 
• Direct writing-based processes.  (Bose et al., 2013) 
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Table 2.4 summarises some of the advantages and disadvantages for some of the AM 
techniques used towards bone tissue engineering applications which forms the basic techniques 
and is still appropriate. 
 
 
Table 2.4:  Advantages and disadvantages of some additive manufacturing techniques 
toward bone tissue engineering applications 




Figure 2.14:  A schematic representation of the 3D print process 
(Bose et al., 2013) 
 
To establish the quality of the resultant part the following essential parameters need to be 
optimised: 
• Powder packing; 
• Density; 
• Powder flowability; 
• Layer thickness; 
• Binder drop volume; 
• Binder saturation; 
• Powder wettability. 
 
Packing density is the relative density of the powder bed after uniform spreading.  To start a 
build, enough powder should be packed homogeneously in a feed bed.  The powder bed is 
created by a set of rollers that spread a layer of powder evenly to a predetermined thickness.  
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Powder flowability determines the spreading ability and is critical in the process.  Flowability 
again is primarily determined by particle size, size distribution, surface roughness and shape, 
where the layer thickness is determined by geometry and powder characteristics.  The printhead 
sprays the binder across the build layer in several passes.  This is based on the instructions in 
the tool path file created from the CAD file (Bose et al., 2013). 
 
After printing, the printed layer is moved under a strip heater to allow the binder to dry and 
prevent spreading between layers.  This is repeated until the designed part is complete.  The 
next step involved is depowdering and involves the removal of loose powder from the printed 
design or body (Bose et al., 2013). 
 
A limitation for this alternative technology is the reduced dimension available for printing 
(typically 20x20x20cm3) due to the low cost for the equipment.  A big 3D object could in 
principle be formed by assembling many smaller parts that were 3D printed.  Another 
advantage or benefit to this entire process is that it produces much less waste than traditional 
manufacturing (Canessa, Fonda, & Zennaro, 2013). 
 
As a summary and based on the background investigations and literature review discussed in 
the above paragraphs it was decided, therefore, to design a customised phantom that will fulfil 
our requirements to successfully achieve the aims of this study which are to: 
 
• Determine the movement seen in previously treated patients from the 4D CT scan sets 
and used during SBRT treatment; 
• Design a thorax phantom to mimic tissue characteristics and internal motion of the 
CTV; 
• Test and compare the customised build phantom in terms of dosimetric characteristics 
applicable to the CT scan as well as linear accelerator, and compare the phantom motion 
with original 4DCT patient data in terms of lesion movement. 
 
The inner thorax is complex with regard to realistic substructures and tumour composition and 
motion.  So, for this study the focus was on minimum, but realistic and dosimetric important 
substructures in the thorax cavity that adds inhomogeneities in the phantom.  This customised 
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build phantom consists of an outer shell, ribs, lung cavities and soft tissue.  Tissue-equivalent 
materials used in the phantom must have similar physical properties to human tissue.   
 
The ideal outer shell will be see-through to better visualise the target motion in the lung and 
have the training component as a bonus associated with it.  The ability to make custom medical 
devices that can be tailored for patient specific needs through additive manufacturing 
technologies through 3D Printing was investigated and used in this study.  3D printing of the 
ribcage will be used since different densities or printing options can be used to match to bone 
or cortical bone.  The lung cavities, for the purpose of this study, will remain air.  A silicone 
gel as substitute for soft tissue was found to preserve better and have other properties that can 
be used in a radiotherapy environment which will be discussed at a later stage during the 
discussion section.  Adipose tissue or fat cells, such as the yellow layer of fat beneath the skin, 




3 Materials and Methods 
3.1 Patient breathing cycle data collection 
3.1.1 Retrospective breathing cycle data from 4D scans 
After ethics approval was obtained from UCT, Human Research Ethics Committee, HREC 
REF number 816/2015, 7 4D datasets of patients were used retrospectively to extract the 
breathing cycle.   
 
 Cancertype Stage Right or Left 
Lung 
Position in Lung 
Pt 1 Lung neoplasm T1a R Lat, inf (1.5cm from 
diaphragm) 
Pt 2 Squamous NSCLC T1a R Post, mid (3.0cm from 
diaphragm) 
Pt 3 Bladder 1 Lung met L Lat, inf (on diaphragm) 
Pt 4 Squamous NSCLC T1a L Post, mid (7.0cm from 
diaphragm) 
Pt 5 NSCLC T4 R Mid (6.25cm from 
diaphragm) 
Pt 6 Inf Brongus/Oesophagus 3 Lung mets L Lat, inf (on diaphragm) 
Pt 6 Lat Brongus/Oesophagus 3 Lung mets L Lat, mid (5.4cm from 
diaphragm) 
Pt 6 Mid Brongus/Oesophagus 3 Lung mets L Post, mid (6.8cm from 
diaphragm) 
Pt 7 Rectum 1 Lung met L Mid, inf (1.0cm from 
diaphragm) 
Pt 8 Lung T2 L Mid, sup (12cm from 
diaphragm) 
 
Table 3.1 Patient Data Sheet 
 
Patient 3 was excluded from the study as it was not 4D scanned, but only with deep inspiration, 
deep expiration and normal.  Therefore, three separate CT scans and not 4D CT scans were 
used in this study.   
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The following statistics could be obtained from the respiratory cycle in a 4D CT scan from 
each of the patients: 
1. Mean breathing rate; 
2. Breath rate range; 
3. Average full exhalation phase; 
4. Average full inhalation phase; 
5. Amplitude range; 






Figure 3.1:  Breathing rate information obtained from the 4D CT scan 
3.1.2 CTV delineation 
The raw 4D CT scans in DICOM format are copied onto CD from the CT scanner application 
where the patients were scanned.  These data sets are imported into the TPS where further 
analysis and data extraction takes place.  During the import process the scans are renamed 
‘Patient1’ and the unique identifier, ID, also renamed to ‘Patient1’.  This is in accordance with 
the ethics rules and regulations with regard to anonymous data usage as mentioned above in 
‘Retrospective breathing cycle data from 4D scans’. 
 
A CTV is contoured separately on each of the 10 phases and named to identify as such.  This 
respiratory phase bin generation from the 4D CT scan is explained in the paragraph above 
under ‘Acquisition of target volumes’ (Rene WM Underberg, 2004).  For each patient, 10 
CTVs are delineated. 
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3.1.3 CTV coordinates 
Motion of the target in the lung volume can be obtained by re-creating the movement of the 
CTVs in the different respiratory phase bins.  When a patient is CT scanned it is placed in a 
coordinate system relevant to a point in the respective area to be scanned.  This point can be 
zeroed and is called the zero coordinate or reference scan coordinate.  Any movement, either 
for set-up purposes of the patient during treatment when considering treatment planning 
options or retrieving motion of organs, can then be used from this coordinate system.  For the 
purpose of this study, the coordinates will be used to track the movement of the CTV in the 
lung during the 10 phases of the breathing cycle as it was 4D scanned. 
 
An interest point or marker is added to the center of each of the 10 CTVs in the 4D CT scan 
set.  The center is identified with the tool in the TPS, ‘Jump to point’ and select ‘Centre of 
CTV’.  This interest point or marker has X-, Y- and Z-coordinates (3D set of coordinates) 
which is relative to the CT reference scan coordinates mentioned earlier.  The coordinates are 
recorded on the CTVs from which the motion can be extracted of the target volume moving in 
the lung. 
 
3.1.4 Breathing cycle paths 
The sets of coordinates obtained and explained in the above paragraph ‘Coordinates of CTV’ 
were inserted into an Excel spreadsheet. 
 
Matlab was used in conjunction with Biomedical Engineering Department, University of Cape 
Town, that assisted with designing of these trajectory pathways of the respiratory cycles of the 
patients. 
 
3.2 Customised phantom design 
3.2.1 Phantom Dimensions 
After review and extensive research on commercially available, as well as customised-made, 
phantoms to mimic movement and the correct density/characteristics of a human thorax, it was 
decided to build a customised phantom that would suit the needs and aim of this study. 
 
From the 4D CT scan sets the following information can be obtained to assist with the design 
of the customised build phantom: 
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• Obtain average measurements of a thorax and lungs to reconstruct as part of the 
customised phantom; 
• Convert the CT dataset of a ribcage to be 3D printed; 
• Check density of the organs to evaluate the materials to be used in the customised 
phantom; 
• Capture breathing cycles for use in this study; 
• Track the path of the CTVs of the patients retrospectively. 
 
3.2.1.1 Average measurements 
Average thorax dimensions are physically measured on the patient data available in the 
treatment planning system.  These measurements are left-right and anterior-posterior from the 
patient outline created on the treatment planning system in use.  Superior-inferior measurement 
are the length of the lung OAR contour delineated on the treatment planning system.  For 
accurate calculation of dose, should the tumour volume be located either superior or inferior in 
the lung, the phantom should extend 6cm beyond the superior/inferior extents of the lung, 3cm 
superior and 3cm inferior. 
 
The lung measurements are the physical measurement from the treatment planning system, 
delineated as the left and right lung as organ at risk volumes as part of the planning process.  
Data are recorded for the patients and an average is calculated.   
 
3.2.1.2 Ribcage 
A ribcage has different densities that vary from bone to cartilage bone.  Perspex can be used, 
but the density is much lower than that of bone.  A suitable substitute was researched, and 3D 
printing investigated as discussed above under ‘Additive Manufacturing Technology’.  Two 
different compositions were explored until the correct density was found that corresponds with 
that of human bone on a CT scan. 
 
The next challenge was the size of the 3D printer, as most printers in the academic environment 
are too small to print a complete ribcage due to cost considerations.  An industrial printer was 
sourced and after samples were printed, scanned and analysed, the appropriate files were sent 
to print the ribcage.  The 3D reconstruction of the ribcage is done in Mimics Materialise.  This 
is a CAD application that uses the patient data set from the CT scan.  The original CT data set 
is imported into the application where after a .stl file is generated.  This format is derived from 
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the name stereolithography, the oldest of the RP technologies.  This is accepted as the golden 
standard of this industry (Peltola et al., (2008). 
 
The CAD data is converted into series of cross-sectional layers.  The computer generated 2D 
layers are created as a solid model by starting at the bottom and proceeding upwards.  Each 
layer is glued or bonded to the previous layer until a solid model is produced of the object 
originally imported into the programme.  Three layering methods can be used, namely liquid-
based, solid-based, and powder-based with a selection of material choices that range from paper 
to various polymers, ceramics and metals (Peltola et al., (2008). For this study the powder-
based RP system was available due to agreement from the dimensions needed for printing the 
ribcage from the patient CT dataset. 
 
3.2.1.3 Density of organs 
To accurately determine the density of the organs to be used in the phantom, the CT dataset is 
used.  When a patient is scanned with a CT scanner, narrow X-rays are sent through the patient 
in an arc motion.  These x-rays are collected with detectors after it has penetrated and moved 
through the patient.  The information collected from the detectors after the x-ray has been 
attenuated are converted into an 3D image due to the 360 degree rotation of the ‘beam’.  The 
CT scan application software collects the data into the CT dataset that you import into the 
treatment planning system.  The treatment planning system converts the Hounsfield units from 
the CT scan to electron density values.  The conversion is from a non-linear graph that is created 
during TPS commissioning and is conventionally named as a ‘CT-to-ED.  This can be used in 
the TPS algorithm for accurate dose calculation purposes. 
 
3.2.1.4 Breathing Cycles/Tracking of CTV 
From the 4D CT scan sets of the patients, the full breathing cycles are traced.  As described in 
above paragraph, ‘Breathing cycle paths’, a map/path is plotted as to how the GTV moves 
during the respiratory cycle and the amount relative to its position in the lung cavity. 
 
3.2.2 Phantom tissue equivalence 
The sample 3D printed blocks that were obtained for evaluating density of bone, were used to 
measure and check transmission through the medium.  The blocks were embedded in the soft 
tissue material (silicon) used in the customised phantom.  Another block with only soft tissue 
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material was also cast to measure and check transmission.  The reference set-up was 3cm 
Perspex for backscatter purposes and the Farmer chamber insert (also Perspex) with 5cm 
Perspex build-up. 
   
 
   
Figure 3.2: (a-d) Phantoms cast with and without 3D blocks in soft tissue material 
 
Both these phantoms were scanned on a CT scanner and imported into the TPS.  Two Treatment 
Planning Systems were used for calculation purposes and comparison of measured results 
against calculated results from the different algorithms used in both systems.  The planning 
systems used were Monaco, version 5.11.02 from Elekta with Monte Carlo Dose calculation 
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and Eclipse, version 15.6 from Varian with AAA and Acuros 15.6 dose calculation models.  
Both these systems are currently used in the department and available for this project.  For 
setup purposes 3cm backscatter perspex plates were used together with a 0.6cc chamber and 
perspex insert.  The reference scan and calculation in the TPSs were only perspex, 3cm 
backscatter, the insert for the Farmer chamber and then 4cm build-up.  For the transmission 
calculation or evaluation, either the 3D blocks were added on top of the chamber or the soft 
tissue material and scanned as such.  The chambers were outlined in the TPS software and 
forced to perspex density.  This is used when calculating the dose in medium and water at a 
specific point in the phantoms.  An interest dose point was dropped at the depth of the ionisation 
chamber. 
 
The same setup was reproduced on the linear accelerator and measurements were made with 
the 0.6cc chamber and each of the phantoms in place. 
 
 
Figure 3.3:  Setup for TPS planning calculation as well as Linac based measurement 
 





   
Figure 3.4:  0.6cc chamber with PTW Unidos 
 
   
Figure 3.5:  3D sample block phantom vs reference (soft tissue) phantom 
 
100MUs were given for all measurements and calculations as on the Treatment Planning 
Systems.  The SSD for the silicon or soft tissue block and 3D block phantom was 89.0cm.  The 
SSD difference between the 3D block and soft tissue block was because the 3D block was 
slightly higher than that of the soft tissue phantom, but this is only 2mm.  The reference scan 
or set-up has an SSD of 95.0cm.  Field sizes 10x10 and 5x5 were measured for two different 
energies, namely 6MV and 10MV. 
 
3.2.3 Phantom motorisation 
Simulation of tumour motions or trajectories in 3D within the lung cavity will be accomplished 






4.1 Patient data 
4.1.1 Retrospective breathing cycle data from 4D scans 
The following statistics were obtained from the respiratory cycle during the 4D CT scan from 
each of the patients: 
1. Mean breathing rate; 
2. Breath rate range; 
3. Average exhalation phase; 
4. Average inhalation phase; 
5. Amplitude range; 





















1 17 16 - 20 59 99 0.66 - 1.26 0.22 
2 11 9 - 13 57 99 0.74 - 1.21 0.12 
4 17 5 - 24 51 85 0.75 – 1.34 0.17 
5 16 8 - 23 56 99 0.64 – 1.28 0.15 
6 14 11 - 19 44 98 0.84 – 1.26 0.13 
7 13 12 - 15 59 98 0.82 – 1.25 0.13 
8 12 9 - 14 53 97 0.84 – 1.38 0.15 
Table 4.1:  Statistics obtained from the respiratory cycle during the 4D CT scans 
Patient 3 was excluded from the study as it was not 4D scanned, but with deep inspiration, deep 
expiration and a normal breathing CT scan. 
 
4.1.2 CTV coordinates 
A CTV is contoured separately on each of the 10 phases and named to identify as such, CTVnil, 
CTV10, etc.  Thereafter an interest point or marker is added to the center of each of the 10 
CTVs in the 4D CT scan set.  This interest point or marker has X-, Y- and Z-coordinates (3D 
set of coordinates) which is relative to the CT reference scan coordinates mentioned earlier.  
The coordinates of the CTVs are recorded, from which the motion can be extracted of the target 




This was done for each of the patients in the study group.  Refer to tables in Annexure A – 
CTV coordinates.  Patient 3 was excluded from this study set, as the patient did not receive a 
4D CT Scan, but an inhalation, exhalation and normal breathing scan. 
 
Once these coordinates were captured (as shown in Annexure A – CTV coordinates), the non-
gated CT (or free-breathing/50% phase) was used to normalise the other phases against.  The 
actual absolute difference in distance of movement from the free-breathing or 50% phase CT 
was determined.  This reference or normalised CT was set to (0, 0, 0) and each of the 
subsequent phase CTs absolute movement was calculated in each direction, X, Y, Z-axis.  
Again, all the patients’ CTV movements were calculated as in the study group except Pt 3, as 
explained in above paragraph.  Refer to tables in Annexure A – CTV movement. 
 
4.1.3 Breathing cycle paths 
The coordinates, depicted above from the tables, plot a path in three dimensions relative to the 
non-gated CT scan.  Therefore, from these coordinates an attempt was made to do 3D plots or 
paths in Excel, but it was unsuccessful.  With the assistance of Biomedical Engineering from 
the University of Cape Town, they could do 3D plots in MATLAB. 
 
 
Figure 4.1:  3D plots of paths in Matlab 
(Video clip Nicolene.mp4) 
The intricate and complicated path of the tumour volumes, as one can see from above 3D plot, 
was a huge challenge.  It is was even further complicated to design a 3D motorised arm to 
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mimic the patient movement and track the path due to the very small movements.  The 
movements were very small, and although at a distance with an amplification factor involved, 
it was extremely difficult to try to replicate these submillimeter movements.  An assumption 
was made to round any movements less than 2mm to 0.  The rest of the values were rounded 
to 1mm.  To bypass the 3D movement of the arm, and keeping it as simple as possible for this 
study, we selected one axis with minimal movement and assumed movement to be negligent.  
This axis was assumed to have 0mm movement and the plot/path can be simplified to a 2D 
movement or path that the tumour follows in the lung cavity. 
 
As per in above paragraph assumption, the Z-axis in Patient 1 is to be assumed a zero movement, 
due to more than half of absolute movements in different phases is 0.0.  In Patient 2, two of the 
axes were found or assumed as zero, and Patient 4 indicated no movement.  But with Patients 
5, 6, 7 and 8, the X-axis and Y-axis were taken as the axis with zero movement, respectively.  
This is atttributed to the fact of the position of the tumour in the lung. 
 
The plots were done but not all plots completed one full cycle, and some paths crossed which 
could not be replicated. 
 
                     Patient 1         Patient 2 
Figure 4.2:  Graphs for movement of tumor in mm for Patient 1 and Patient 2 
 





            Patient 5     Patient 6 (Lat) 
Figure 4.3:  Graphs for movement of tumor in mm for Patient 5 and Patient 6 (Lat) 
 
 
Patient 6 (Med) 
Figure 4.4:  Graphs for movement of tumor in mm for Patient 6 (Med) 
 
Patient 6 (inf): No movement could be calculated according to assumptions accepted for this 
study. 
 

























                            (a)                        (b) 
 
(c) 
Figure 4.6 (a-c) Physical templates of breathing cycle paths 
 
Templates of the design of paths as per coordinates from 4D scans and 2D plots as shown 
above. An ‘average’ path was created from the points, as well as connecting the first and last 
point from the coordinates from which the plot/path was constructed.  A track was re-designed 
for the motorised arm that could more easily follow the 2D path.  This is explained in paragraph 
4.2.3.4 ‘Fourth Design’ to simply the motorised arm design that forms part of this project.  Only 
Patient 1 and 5’s paths were re-designed.  This is depicted in the coloured in area on the graphs 
in Figure 4.7.  The paths that replicated only a straight line as the plot that mimics the movement, 







Figure 4.7:  Paths for Patient 1 and Patient 5 
 





4.2 Customised phantom 
4.2.1 Phantom dimensions 
Below is a simplistic design of a customised phantom with a motor propelling an arm at a 




















Figure 4.9:  Schematic side/lateral view 
 
As a first step to make this design a reality, the body or shell of the phantom must be created.  
This is all calculated from average measurements from the 4D CT scans of the retrospective 
patients used during this study. 
4.2.1.1 Average measurements – Thorax (Shell) 
The average thorax dimensions are calculated as 34.11cm, 29.42cm and 25.07cm for left to 
right, superior-inferior and anterior-posterior distance respectively, from the patients in the 
















Customised Built Phantom 
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inferior, to allow for dose calculation accuracy should the CTV be located either superior or 
inferior in the lung cavity. 
 
 Left-right (cm) Superior-inferior (cm) Anterior-posterior (cm) 
Pt1 32.2 25.9 29.1 
Pt2 30.6 22.7 21.2 
Pt3 38.4 24.0 27.6 
Pt4 34.9 23.1 24.8 
Pt5 33.8 21.4 23.6 
Pt6 37.1 24.3 24.0 
Pt7 34.3 22.2 25.7 
Pt8 31.6 23.8 24.5 
Average 34.11 23.42 25.07 
6cm added sup-inf  29.42  
Table 4.2:  Average measurements for thorax dimension 
 
A mould was reconstructed simulating a thorax to house the relevant organs at risk (OAR) from 
the above-mentioned average values of the retrospective patients used in the study. 
 
A 3D model of a set of anterior and posterior ribs was presented (discussed under ribcage) so 
that an ultra high impact acrylic cast could be made to house the ribs, lungs and then be filled 
with a tissue equivalent material.  A subject was chosen on the measurements taken from the 
superior, middle and inferior levels of the ribs.  The subject was informed of the procedure and 
consent obtained to manufacture this two-piece Plaster of Paris impression.   
 





Figure 4.10:  Anterior mould (A) 
 
 




Figure 4.12:  Posterior mould (A) 
 
 
Figure 4.13:  Posterior mould (B) 





4.2.1.2 Average measurements – lung 
The average values to reconstruct the lung moulds are 10.60cm, 23.30cm and 18.27cm for left 
to right, superior-inferior and anterior-posterior distance respectively, from the patients in the 
study. 
 
 Left-right (cm) Superior-inferior (cm) Anterior-posterior (cm) 
Pt1 11.1 25.9 21.4 
Pt2 10.3 22.7 15.8 
Pt3 10.2 24.0 18.7 
Pt4 10.5 23.1 16.7 
Pt5 10.5 21.4 17.7 
Pt6 - - - 
Pt7 10.3 22.2 19.4 
Pt8 11.4 23.8 18.1 
Average 10.60 23.30 18.27 
Table 4.3:  Average measurements for lung dimensions 
Note Patient 6 is ignored in this calculation of averages as the R Lung was collapsed and L 
Lung over-used because of R Lung incapacity. 
 
Screenshots from the TPS of lung 3D wire images were made, saved and used as an example 
of what the lung moulds must look like/represent once finished. 
   





Figure 4.14:  3D wire screenshots of lung from (a) feet, (b) anterior 
and (c) lateral view, respectively 
 
These lung moulds were reconstructed on Stillam software, Alphacam 2016 R1.  Alphacam is 
CAD CAM software to aid in the design and manufacturing of woodworking, metal and stone 
cutting.   
 
Medium density fibreboard (MDF) was used as the material for the moulds.  MDF is a high 
grade, composite material that performs better than solid wood in many areas. Made from 
recycled wood fibres, combining it with wax and resin, MDF is machine dried and applying 
high pressure and temperature to produce dense, stable sheets or panels. MDF is more stable 
than solid wood and stands up better to changes in heat and humidity.   
 
 




A Biesse Klever 1836 G FT CNC Router with a Matrix Vacuum bed was used in the 
construction of the lung OARs.  A CNC router is a computer controlled cutting machine related 
to the hand-held router used for cutting various hard materials, such as wood, composites, 
aluminium, steel, plastics and foams. CNC stands for computer numerical control.  Slabs or 









The lung moulds were formed layer by layer as described above and shown below in the photos. 
 
   
                                Figure 4.17(a)      Figure 4.17 (b) 
 
Figure 4.17 (c) 




The cast or shell reconstructed from these moulds is done with a vacuum wrap machine.  A 
‘dummy’ mould was constructed in the same manner as the lung moulds to check if the vacuum 
wrap of thermoplastic would succeed.  Below a photo of this preliminary check. 
 
 
Figure 4.18:  Dummy mould to investigate if wrapping process would work  
It was successful and the process could continue. 
 
4.2.1.3 Construction of thorax and lung moulds 
The customised build thorax and lung moulds were vacuum wrapped with thermoplastic.  
Polycarbonate (PC) sheets were used to form the thorax and lungs from the mould.  It was 
vacuumed in the desired shape.  2mm thick PC sheet was used for the thorax and 1mm for the 
lungs.  A Woodtech Mechatronics Technowrap Plus Double Bed Vacuum Press with 2900mm 




Figure 4.19:  Vacuum wrapped machine -  Woodtech Technowrap 2900mm bed 
See Annexure C - Thorax for the full description of the process to vacuum wrap the moulds. 
 
   
Figure 4.20:  (a+b) Outer shell of thorax 
An opening inferior of the shell will allow mimicking movement of the tumour in the lung. 
 
The same process was followed with the lung moulds after manufacturing, explained in 
Annexure C - Lung.  The MDF lung moulds were fitted in a jig, thermoplastic of 1mm was 
added and it was heated.  Thereafter the vacuum process was followed, half settings for 
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temperature and pressure were used due to the fact of the thinner and smaller moulds used to 
fabricate the lung shells. 
 
4.2.2 Patient tissue equivalence 
4.2.2.1 Body 
As discussed under ‘Construction of thorax and lung moulds’ above, the material used for the 
body or thorax shell was 2mm thermoplastic.  It is sturdy enough to keep shape for the purpose 
of this study.  Also, the phantom will always be scanned with a CT scanner to take the density 
of the material involved in the phantom into account, when dosimetric calculations need to be 
done. 
4.2.2.2 Tissue 
The soft tissue surrounding the ribcage and filling the thorax shell was investigated and a 
workable solution for the soft tissue in the thorax shell must be, except for a density match, 
also non-biodegradable.  This means that the phantom needs to be stored under normal 
circumstances and not e.g. under a certain temperature and only for a certain amount of time, 
and then needs replacement.  This will increase cost of the phantom and use will be limited to 
a specified period only or ‘end-by-date’. 
 
Encapso K is a water clear encapsulation or display rubber (silicone) that looks just like water 
and is ideal for a variety of encapsulation and display purposes.  This is ideal for the thorax 
phantom as the see-through property of the compound will be an added advantage.  As per all 
previous materials, this also was checked to confirm the equivalence of soft tissue in a human 
body. 
 
As one can see from the CT scan in the Figure 4.21, the Hounsfield number of the rubber 
compound to be used as soft tissue equivalent was indeed comparable to water.  In 
radiotherapy, water is equivalent to soft tissue for phantom-based calculations and evaluations.  
This value is 0 and this clear medium indicated on the CT scanner a value of 134HU, which is 





Figure 4.21:  CT scan of Encapso K to verify density 
 
Two clear liquids (part A and B) are mixed in equal amounts (parts) after vigorously shaking 
to mix each one separately before commencing with the mixing of the two liquids.  Mix for at 
least five minutes, making sure that all is blended especially against the sides of the container.  
The mixture at first appears to be cloudy but will clear after a few minutes.  Please see 
Addendum D for Specifications and Manual of Encapso K.   
 
It is now ready for pouring into the thorax shell.  The printed ribcage and lung shells were fixed 
in position with fishing line to keep it up straight while hanging in the thorax with the silicon 












   
      (a)        (b) 
 
(c) 
Figure 4.23:  (a+b) lung cavities within ribcage handing down 
(c) Weight bearing down in lung cavities to not float in liquid 
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(a+b) lung cavities within ribcage hanging upside down (c) Weight bearing down in lung 
cavities to not float in liquid 
 
Refer to Addendum E for the complete pouring process and set of the Encapso K compound. 
 
 




A CT scan was performed on the customised phantom.  This was done to evaluate the phantom 
against the retrospective patient CT data from which the original files were extracted to use in 








The organ at risk that needs to be simulated in the phantom is the lungs.  To keep the phantom 
simple, it was decided for this study to keep the lungs as air cavities. 
 
4.2.2.4 Ribcage 
As was previously mentioned, to find the correct match for rib bone, samples were printed, 




The first 3D printer to be used in this study was from Biomedical Engineering, University of 
Cape Town.  The 3D printer is a Zortrax M200, desktop size. 
 
   
Figure 4.26:  Zortrax M200 desktop 3D printer 
Although we knew the printing size of the printer was a problem, the first step was to match 
the density and the relevant materials or components used during the printing process. 
 
Barium powder was supplied by Groote Schuur Hospital.  It is a dense powder compared to 
nylon.  The 3D outer housing (printed in a matrix) of the sample blocks (dimensions of 10.0 x 
10.0 x 1.0cm) was printed with nylon and filled with barium powder.  The red sample was only 
partially filled with barium and the pink sample block was fully filled with barium.  The powder 
was evenly spread with a knife, but 5% of the periphery holes were partially filled. 
 
Figure 4.27:  Red medium filled with barium and pink is full filled with barium powder 
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Alone the barium powder filled matrix did not fulfil the density requirement that we needed to 
replicate rib bone.  This was due to not completely being able to fill the matrix that was printed 
on the 3D printer or housing.  Also, if this was true for only a simple matrix printed, then a 
complex 3D print, such as a ribcage, will not be successful.  A suggestion was to mix the 
barium powder with water to have a liquid that would fill the holes.  The following concerns 
were raised by Biomedical Engineering: 
Concern 1: The plate on which the 3D printing happens is 110 degrees, enough to evaporate 
water; and 
Concern 2: The hot water might also eat into the material and deplete it. 
Therefore, in their opinion the liquid barium technique might not work and was abandoned. 
 
Another denser material to use in the 3D printer was sourced and the following material was 
suggested: 
 
Table 4.4:  Potential additive manufacturing materials 




Table 4.5:  Properties of additive manufacturing materials 
(TS Srivatsan, 2015) 
Unfortunately, the Z Bond (cyanacrylate) material was not compatible with the Zortrax M200 
3D printer used at Biomedical Engineering Department, University of Cape Town as it uses 
only LPD (Liquid Plastic Deposition) technology.  The Zortrax M200 is best for rapid 
prototyping. 
 
Another company, Rapid 3D in Howick, KwaZulu-Natal, South Africa, was researched as their 
business is 3D printing and supplying of 3D printers.  Again, samples were requested from the 
company with the printer 3D Systems ProX SLS 500 using Selective Laser sintering (SLS) and 
fusion Type laser. 
 
Figure 4.28:  ProX SLS 500 3D Printer 
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The build material used in the ProX SLS 500 Printer is DuraForm ProX PA mixed with calcium 
sulfate hemihydrate, both a physical appearance and state of a white powder.  Specification 
sheets available in Specification and Manual addendum. 
 
 
Figure 4.29:  3D blocks from Rapid 3D 
 
To assess the density of the blocks, a CT scan was performed to extract the Hounsfield number 
(HU), and during conversion of CT to Electron Density (ED) values in the Treatment Planning 
system.  It was confirmed that the density is correct and what was needed for this study.  As 
per the previous reference in Table 4.5 for additive material, this correlates well with the values 
(CT number 850.17 and density 1.44g/cm3) between 896 and 1079HU or 1.653ED from the 




Figure 4.30 (a) 
 
Figure 4.30 (b) 
Figure 4.30:  TPS evaluation of 3D sample blocks from Rapid 3D 
 
As discussed under ‘Materials and Methods – Customised Phantom design’, a .stl file was 
generated from the CT scan and printed on a ProX SLS 500 3D printer.  The measurements 
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and size of the ribcage were checked against the maximum printing size of the 3D printer as 
well as the thorax shell made. 
 
Figure 4.31:  Table ProX SLS 500 manual specifications 
(Specifications and manual addendum) 
 
Figure 4.32:  Ribcage reconstructed from CT scan 
in Mimics Materialise (CAD application) 
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The 3D print was received from Rapid 3D company and the ribcage was scanned and evaluated 
against the sample blocks originally tested from the company.  First, during the courier process, 
two ribs broke off and had to be repaired.  An enquiry was made as to what adhesive could be 
used and it was advised that a standard two-part epoxy can be used (Pratley’s Quick Set Clear 
Epoxy).  Due to the composition of the glue, a small part was first mixed and scanned on the 
CT scanner to ensure there are no artefacts from the glue due to possible metal or other 
materials that could cause ‘streaky’ artefacts.  This would cause inaccuracies during dose 
calculations on the TPS.  No artefacts were found when the two-part epoxy was scanned. 
 
   
                             Figure (a)      (b) 
Figure 4.33:  3D print of ribcage (a) Sternum (anterior) and (b) Vertebrate (posterior) 
 
The values obtained from the CT scan and imported into the TPS for density values were far 





Figure 4.34:  3D printed ribcage values in TPS 
A reprint was requested from the 3D printing company of only a section of the ribcage to verify 
that not the same material was used during the sample blocks and first print of the ribcage.  
This was established and confirmed by the company.  This was due to two reasons (a) the 
original material from the sample blocks was very fragile due to the denser composition of the 
material and (b) the complexity of the contour or object (ribcage) that needed to be printed.  
Instead, the normal nylon material was used as it is much tougher and easier to work with.  The 
reprint section was checked to make sure that sternum, vertebrae and ribs were included in the 





Figure 4.35:  Reprint of section of ribcage done in Mimics Materialise 
(CAD application) 
 
   





Figure 4.37:  CT scan of reprint of section of ribcage 
The re-print of the section of the ribcage with the denser material composition as with the 
sample blocks proved to have the correct density as specified for cortical bone (TS Srivatsan, 
2015). 
4.2.3 Phantom motorisation 
To be able to replicate movement of the tumour in the lung and therefore mimic a breathing 
cycle or breathing path of a patient, a motorised arm needs to be designed.  This motorised arm 













4.2.3.1  First design 
As discussed before under ‘Customised Phantom Design’, below is a simplistic first design of 
a customised phantom with a motor propelling an arm at a designated speed and cycle/path to 



















Figure 4.39:  Schematic side/lateral view 
 
 






















Customised Built Phantom 
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The fourth dimension (time) is incorporated with this motion taking place during the treatment. 
 
4.2.3.2 Second design 
An adaptation to the first design was necessary to get a practical solution for the tumour 
movement that the arm will mimic in the customised phantom. 
 
A height adjustable arm on the first section of the design is for positioning in the lungs in the 
anterior-posterior direction as well as for lateral adjustment.  Once the position in the lung has 
been achieved, the next section will be the tracking of the path of the tumour in the lung cavity 
according to the 4D CT scan set.  There are two components to this section: the actual path that 
the arm will follow; and the motor that will drive this arm in the path at the designated speed, 
again according to the information extracted from the 3D CT scan set.  The path was explained 
under ‘Results – Path of the breathing cycle’.  The motor is a simple design that will run against 
revolutions according to the breathing cycle in seconds and revolutions or completion of the 
path (in seconds) per minute.  The motor is small and lightweight as it is fixed to the arm in the 
first section of the design. 
 
The third section of the design will hold the actual target and film in a vertical and/or horizontal 
plane for dosimetric measurements.  The template path is followed with the motorised arm in 
the second section.  The third section of the design is in the customised phantom in the lung 
cavity. 
 
The whole mechanism or design described above is positioned on a calibrated or marked plate 
to set and have the initial position or zero position relative to the phantom.  This is necessary 
to monitor and record the exact movement of the tumour during the breathing cycle.  This is a 










4.2.3.3 Third design 
After completion in theory of the second design, Biomedical Engineering, University of Cape 
Town was approached for assistance.  The purpose of the customised build phantom was 
explained, and the third design was proposed by the Biomedical Engineering Department. 
 
The first section is still an adjustable arm, but just more robust and stronger to hold and balance 
the entire ensemble. 
 
The path template in the second section is refined in this design.  Due to the small movements 
encountered in some of the 4D CT study sets, a one-to-one path is not possible.  A scaling 
factor must be incorporated to assist in the motorised movement of the arm, otherwise this will 
be practically not a viable solution to try and follow these very small movements.  This part is 
positioned inside the lung cavity and is scaled proportionally from the path template to the 
actual movement that is needed to be comparable to the 4D CT scan set.  These movements are 
in some cases extremely small, therefore the scaling of the path from the template to the film 
to be able to mimic this movement realistically. 
 





Figure 4.42:  Third design of motorised arm 
(Software used for 3D modelling: Solid work, version 2015) 
Some parts of the assembly/motorised arm in this design can be 3D printed, but not all at this 
stage.  The name of the 3D printer that can be used is the Zortrax M200.  The expected number 
of components that can be printed is more than 30 components. 
 
4.2.3.4 Fourth design 
For this design a correction was made in terms of the orientation of the phantom and the 
placement of the motorised arm.  As can be seen from the third design, the arm was moving in 
an anterior-to-posterior direction, which is not a realistic replication of a patient on a CT 
scanner bed or linear accelerator bed and treatment of the patient.  So, in this design two 90° 




The arm into the customised build phantom was extended as well, as the path template was in 
the field of view of the CT scanner and linear accelerator.  This is crucial as the template will 
have an influence on the imaging and attenuation on the CT scanner and linear accelerator in 
terms of artefacts and dosimetric calculations, respectively. 
 
Again, only 2D motion is enabled to track the path of the breathing cycle and not 3D as 
originally envisaged. 
 
    
Figure 4.43 (a)         Figure 4.43 (b) 
 
Figure 4.43 (c) 




   
Figure 4.44 (a)    Figure 4.44 (b) 





   
Figure 4.45 (a)      Figure 4.45 (b) 
 
Figure 4.45 (c) 
Figure 4.45:  Different views of the fourth design (a+b) Side views (c) top view 
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4.3 Dosimetric results 
4.3.1 Linac based results 
The following results were obtained from the linac based measurements for 100MUs, isocentric 
setup – 100cm SAD, 5cm measurement depth, with a Farmer type chamber for both a 10x10cm 
and 5x5cm field size in terms of transmission of the silicon or tissue equivalent material and 
the 3D print or bone equivalent material.  Detailed measurement values are given under 
Annexure F. 
 
Figure 4.46:  Transmission of silicon and 3D print in table format 
 
Figure 4.47:  Transmission of silicon in graph format 
Transmission of silicon
6MV 10MV
10x10 5x5 10x10 5x5
0.8215 0.7896 0.8526 0.8269
Transmission of 3D prints
6MV 10MV
10x10 5x5 10x10 5x5




Figure 4.48:  Transmission of the 3D prints in graph format 
 
4.3.2 Treatment planning system calculation results 
The results were obtained from the Treatment Planning Systems, Elekta Monaco and Varian 
Eclipse, at the same point of measurement as depicted in ‘Customised Phantom Design’ under 
‘Methods and Materials’. 
 
4.3.2.1 Monaco treatment planning system 
In the Monaco treatment planning system, Monte Carlo calculations are used.  For tissue 
equivalent materials, the dose difference between the dose to medium and dose to water 
calculation properties is said to be 1-2%.  Whereas for high density materials such as bone or 
metal it could be as high as 12%. 
 
4.3.2.2 Eclipse treatment planning system 
4.3.2.2.1 Anisotropic Analytical Algorithm (AAA) calculation 
The Anisotropic Analytical Algorithm is based on the superposition/convolution method.  
Primary and scatter components are used from Monte Carlo to calculate dose by superposition 
of dose kernels and is done in the beamlet and lateral directions.  For the beamlet direction it 
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includes radiologic scaling of dose deposition functions, whereas the lateral directions are 
based on electron density scaling of photon scatter kernels (Rana, 2014). 
 
The calibration curve of the CT scanner is used to convert the Hounsfield Unit value to relative 
electron density (Eclipse Photon and Electron Algorithms Reference Guide). 
 
4.3.2.2.2 Acuros External Beam Algorithm (Acuros XB) calculation 
Acuros was developed as a new grid-based Boltzmann solver (GBBS) from Atilla and 
optimised for radiotherapy dose calculations.  Atilla is a general-purpose radiation transport 
software that makes use of raytracing.  The GBBS solves the linear Boltzmann transport 
equation (LBTE) that describes macroscopic behaviour of ionising particles as they travel 
through matter and interact with surrounding matter in each volumetric domain.  There is a 
general trade-off between speed and accuracy, and this is the main difference between the 
Monte Carlo simulations (EGSnrc code) and the Acuros software.  Acuros has compared well 
with Monte Carlo simulations when performed to tight statistical uncertainties (Vassiliev, 
2010). 
 
The calibration curve of the CT scanner is used to convert the Hounsfield Unit values to mass 
density.  From the derived mass density, Acuros XB determines the material composition of 
voxels in the image (Eclipse Photon and Electron Algorithms Reference Guide).  From the 
material composition or properties of the voxels, the macroscopic energy deposition cross-
section and atomic density is used for Acuros Dose to medium calculations.  Energy deposition 
for water are again then used for Dose to water calculations (Rana, 2014). 
 
Refer to Annexure G for detailed calculated values in table format on the two different 
treatment planning systems and their respective calculation algorithms as mentioned in the 
preceding paragraphs. 
 
For the silicon or tissue equivalent material used, the difference between the TPS calculation 
algorithms versus the measured values on the machine is as shown below with the largest 





Figure 4.49:  Silicon or tissue equivalent material 
 
In the case of the 3D printed material, which we took as equivalent to the density of bone, the 
biggest outlier was consistently 3.2% for the 6MV, 5x5cm field size for Monaco Dose to water 












The three aims of this study: 
1. Determine the movement seen in previously treated patients from the 4D CT scan sets 
and used during SBRT treatment; 
2. Design a thorax phantom to mimic tissue characteristics and internal motion of the 
CTV; and 
3. Compare the customised built phantom in terms of tissue characteristics applicable 
from the TPS to the linear accelerator. 
 
5.1 Patient data collection 
The breathing cycle obtained from the respiratory cycle in the 4D CT scan from each of the 
retrospective patients in this study indicated different paths in most of the patients.  This cycle 
was tracked by means of an interest point that was dropped in the centre on each of the different 
CTVs created on each of the 10 phases from the 4D CT scan.  From the 3D coordinates of the 
interest point, a path could be plotted to mimic the motion of the CTV in the lung in three 
dimensions.  With this path tracked and running at the breathing rate of a patient, the fourth 
dimension can be included.  But as discussed previously, this can be accomplished with an 
automated computer programme that can read the patients’ breathing cycle details from the 4D 
CT scan, input of coordinates as depicted previously and executing the movement within the 
customised build thorax phantom.  The result of these paths was dependent on the location of 
the CTV in the lung.  As soon as the volume is adjacent or fixed to either the chest wall or 
medial wall of the lung/large vessels, the movement is restricted.  When the volume is in the 
middle of the lung lobe or inferior, the tendency for movement is much more due to ‘free’ 
movement in the lung and/or the diaphragm that moves during inhalation or exhalation.  The 
movement was confirmed with this study as 7mm in cranio-caudal as the most against the 
article (Wolthaus et al., 2008) that in the upper thorax the most movement was 3.7mm in 
cranio-caudal direction and in lower thorax also in cranio-caudal direction 11.6mm.  The 
movement obtained from the 4D scans was smaller, however, to what originally was 




5.2 Customised phantom design 
From the eight patients used in the study only two patients had the same 2D movement, the 
other six patients had complicated paths that were tracked.  These intricate paths had to be 
simplified to mimic and create desired patterns for a motorised arm that was able to be 
replicated on a scale for the customised phantom. Due to time constraints and resource 
limitations, only Patients 1, 4 and 5’s paths were re-designed.  This was to establish if the 
constraints and simplified versions of the original patient paths data could in fact be physically 
replicated on the motorised arm.  This was indeed the case.  Another constraint was the amount 
of movement in millimeters to try and replicate with a motor.  The accuracy and detailed 
movement are a problem but can be accommodated in an automated computerised program to 
enable millimeter accuracy and movement. 
 
As described for the fourth design, to realise and accommodate 3D movement in the motorised 
arm design, computerised planning of the 3D path of the tumour will need to be investigated.  
This falls outside the scope of this study. It can possibly be assessed for a future project to 
incorporate this specific design. 
 
As for the structural design of the thorax phantom, alignment of the two halves of the body cast 
is very important.  Fortunately, after trial and error, this could be rectified, and the 
manufacturing of the thorax phantom could continue.  The perspex used for the outer shell as 
2mm and lungs, thickness of 1mm, sufficed for the purpose of this study. 
 
Soft tissue or water equivalent materials are always a challenge in radiotherapy and to be 
sustainable to be used over extended periods of time and the conditions where it is stored.  
Normal Apgar gel decays over a period and therefore is not useful in the making of a phantom 
that is supposed to last for some time.  Water that is the next best solution, normally has the 
trouble of waterproofing and eventually the water also only lasts for a limited period.  The 
silicone gel as a non-biological material used during this study was proven to be water 
equivalent or soft tissue equivalent, exactly what was needed.  Even after months after 
manufacturing or building the thorax phantom and the use of this specific silicon material, there 
was only a slight discoloration of the material storing it under normal temperature and humidity 
conditions in an office.  The photos shown in Figure 5.1 were taken more than a year after 




Figure 5.1:  Customised made thorax phantom with only slight discolouration, 
but otherwise no other effects or biological decay 
The only two drawbacks or negative points on this silicon is that it takes some time to set, 
especially the quantity that was needed to fill the outer thorax shell and during manufacturing, 
if spilled, it is very slippery and dangerous on the floor. 
 
Another definite possibility of use for this silicon is to be used as a tissue equivalent material 
in build-up or bolus for patients with superficial lesions or separation less than 10cm.  Due to 
the pliable capabilities of the silicon, it can be shaped and sized to any customised field size 
that is needed.  A template mould will need to be made of the area applicable and then the 
silicon can be mixed and poured and set in the negative of the mould.  This will then fit perfectly 
to the patients’ anatomy and can be preferably scanned with the ‘silicon bolus’ material to 
accurately calculate the dose needed to the volume.  Certain 3D printing techniques to simulate 
customised bolus are currently available on the market, but are extremely costly due to the 
printer needed, and the material used is not 100% soft tissue equivalent.  This could influence 
the dose build-up that is needed during superficial treatment. 
 
Bone equivalent material for testing or quality assurance purposes has always been a 
contentious issue.  Normal practice would be to use a high-density perspex, but this does not 
simulate or replicate bone density that well.  In this study with the 3D printing materials initially 
used for the test blocks and from the second 3D print, it was established and verified that a 
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similar material with bone density properties was successfully manufactured/3D printed and 
could be used in this study and for further projects in future.   
 
The reprint requested from the 3D printing company of only a section of the ribcage to verify 
that not the same material was used during the sample blocks and first print of the ribcage that 
was established and confirmed by the company was due to two reasons:  (a) The original 
material from the sample blocks was very fragile due to the denser composition of the material; 
and (b) the complexity of the contour or object (ribcage) that needed to be printed.  Instead, the 
normal nylon material was used as it is much tougher and easier to work with. 
 
Although there was concern for fragile components and therefore handling/breakage of 3D 
printed pieces from the correct materials, as mentioned above, from the company, it was noted 
that the ribcage was sturdy in design and as soon as it was set in the silicon material, it was 
protected from accidental breakage.  During the design of the ribcage, the density values that 
was extracted from the CT scan and used in the 3D printing design software, needs to be 
adjusted to accommodate less dense tissue and not be printed, and rather only higher density 
bone structures.  This could be the cause of the fragile rib bones that were printed but is in fact 
the costal cartilage that is a flexible connective tissue and strengthened by collagen fibres.  This 
connects the ‘true’ and ‘false’ ribs to the sternum and is not bone as such. 
 
5.3 Dosimetric outcome 
The transmission measured on the Elekta Synergy for the silicon material on average for 6MV 
and 10MV is 80.6% and 84.0%, respectively.  The 3D prints’ transmission measured is 76.2% 
and 80.0% for 6MV and 10MV, respectively. 
 
Comparing these measured values for silicon against the TPS calculated values for the different 
algorithms, the largest discrepancy is 3.32% for the Acuros, Dose to Medium for the 10MV, 
10x10cm field size.  The Monaco calculates the transmission as less through this silicon 
medium, whereas the Eclipse sees it as more.  The same scenario is seen with the 10MV data.  
In the case of the 3D print material, for all the calculations it is seen as less than the measured.  
With the 10MV Acuros, both dose to water and dose to medium, the transmission is more with 
0.53% and 0.38%, respectively.  This can be assumed as equal to the measured values due to 
uncertainty in measurement equipment.  The 3D print material has a much higher density and 
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could therefore be more accurately calculated with the mass density associated within the 
algorithms and as explained in previous paragraphs.  As reasoned, this is because Acuros Dose 
to Medium takes mass density into account whereas the other mentioned algorithms make use 
of relative electron density.  Although Monaco makes use of Monte Carlo which is the same 
principle, it leans more strongly on the attenuation coefficient and stopping power ratios. 
 
5.4 Imaging of phantoms 
Imaging sets were acquired of the only silicon and 3D print with silicon phantoms, as well as 
the re-print of ribs with the higher density 3D additive manufactured material.  The soft tissue 
or silicon phantom shows up as a grainy picture as expected for a water phantom during normal 
MV Electronic Portal Imaging (EPI).  The same as for the Cone Beam CT that was acquired 
with kV imaging on the Elekta Synergy machine. 
 





Figure 5.3:  kV CBCT of silicon or soft tissue equivalent material phantom 
 
 





Figure 5.5:  kV CBCT of 3D print phantom 
 
 






Figure 5.7:  kV CBCT of reprint of 3D printed ribs and sternum. Due to 
attenuation around the ribs there was an excess of scatter from the kV beam 
 
5.5 Clinical radiotherapy key metrics summary 
The silicon material and bone printed in 3D as with the final print version, correlates well with 
HU numbers for a CT scan compared to normal patient CT scans for soft tissue and cortical 
bone equivalent, respectively. 
 
Comparing transmission for these materials on a linear accelerator for 6MV and 10MV energy, 
the deviation from planned versus measured dose varies between 1.67% to 3.32% and 0.45% 
to 2.30%, respectively for the silicon material and between 0.77% to 3.22% and 0.17% to 
2.57% for the 3D printed bone for 6MV and 10MV, respectively.  For the 3D printed material, 
the dose to medium algorithms compares better as to the dose to water.  This could be since for 
dose to medium, mass density curves are taken into consideration when doing calculation, and 
not the electron density values or curves.  Therefore, the silicon material also compares better 
with the dose to water in general, than the dose to medium calculations, as the silicon represents 





























































Table 5.1:  Summary of the key metrics for clinical use in radiotherapy: 








The outcome of this research study is to determine the movement of tumour volumes in lung, 
and track the breathing cycle thereof in a customised build thorax phantom that replicates tissue 
equivalent organs to accurately calculate dose to the tumour volumes and surrounding organs 
at risk.  The design of a thorax phantom and creating the breathing cycle and tracking in a 2D 
pathway was successfully accomplished, and further future projects can be investigated to 
enhance and improve on the capabilities of such a phantom.  This could include extending the 
path from 2D to 3D movement, but this will only be possible as a robotic arm, as discussed 
previously, and for possible investigation in a further study or project. 
 
In future studies the role of different and customised margins per patient and the influence on 
treatment outcomes and side-effects of lung volume in high-dose areas can be investigated.  
For this study, the design of a suitable phantom to mimic target motion in lung is the end point 
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CT Phase sets X-coordinate (cm) Y-coordinate (cm) Z-coordinate (cm) 
CT – non-gated -11.50 0.00 -2.90 
nil -11.15 -0.30 -2.52 
10 -11.30 -0.30 -2.50 
20 -11.19 0.00 -2.50 
30 -11.12 0.30 -2.75 
40 -11.10 0.30 -2.73 
50 -11.12 0.45 -2.81 
60 -11.08 0.45 -2.85 
70 -11.10 0.30 -2.81 
80 -11.16 0.00 -2.85 
90 -11.18 -0.30 -2.61 
CT Phase sets X-coordinate (cm) Y-coordinate (cm) Z-coordinate (cm) 
CT – non-gated -7.79 19.25 -12.37 
nil -7.87 19.40 -12.33 
10 -7.82 19.40 -12.37 
20 -7.84 19.55 -12.37 
30 -7.96 19.55 -12.35 
40 -7.96 19.55 -12.33 
50 -7.93 19.55 -12.30 
60 -7.95 19.55 -12.32 
70 -7.92 19.55 -12.34 
80 -7.91 19.55 -12.32 
90 -7.90 19.40 -12.28 
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CT Phase sets X-coordinate (cm) Y-coordinate (cm) Z-coordinate (cm) 
CT – non-gated 8.01 11.15 -18.24 
nil 7.94 11.05 -18.32 
10 8.00 11.05 -18.28 
20 7.93 11.25 -18.28 
30 7.99 11.15 -18.26 
40 7.95 11.15 -18.23 
50 8.03 11.15 -18.25 
60 7.92 11.15 -18.23 
70 7.96 11.15 -18.27 
80 7.91 11.15 -18.35 
90 7.97 11.15 -18.28 
CT Phase sets X-coordinate (cm) Y-coordinate (cm) Z-coordinate (cm) 
CT – non-gated -6.40 -36.65 -1.60 
nil -6.40 -36.55 -1.28 
10 -6.33 -36.55 -1.17 
20 -6.30 -36.65 -1.10 
30 -6.27 -36.55 -1.06 
40 -6.33 -36.55 -1.08 
50 -6.26 -36.45 -1.19 
60 -6.35 -36.35 -1.27 
70 -6.34 -36.35 -1.33 
80 -6.33 -36.35 -1.30 
90 -7.90 19.40 -12.28 
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Patient6 (1st lesion – Lat Lung): 
 






CT Phase sets X-coordinate (cm) Y-coordinate (cm) Z-coordinate (cm) 
CT – non-gated 15.08 0.35 -0.06 
nil Coordinates does not match rest of scans/phases - ignore CT set 
10 15.29 -0.35 0.02 
20 15.24 -0.35 0.02 
30 15.20 0.25 -0.30 
40 15.28 0.45 -0.30 
50 15.08 0.35 -0.06 
60 15.21 0.55 -0.26 
70 15.23 0.45 -0.32 
80 15.10 0.45 -0.10 
90 15.21 0.35 -0.33 
CT Phase sets X-coordinate (cm) Y-coordinate (cm) Z-coordinate (cm) 
CT – non-gated 6.77 0.05 -8.74 
nil 6.77 -0.35 -8.75 
10 6.77 -0.35 -8.70 
20 6.77 -0.15 -8.78 
30 6.77 -0.15 -8.77 
40 6.75 0.05 -8.76 
50 6.77 0.05 -8.74 
60 6.75 0.05 -8.80 
70 6.73 -0.05 -8.82 
80 6.77 -0.05 -8.79 
90 6.77 -0.25 -8.76 
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Annexure A  2:  CTV Movement 
 
Patient1: 
CT Phase Sets X movement (mm) Y movement (mm) Z movement (mm) 
Non-gated 0 0 0 
nil -3.50 3.00 -3.80 
10 -2.00 3.00 -4.00 
20 -3.10 0.00 -4.00 
30 -3.80 -3.00 -1.50 
40 -4.00 -3.00 -1.70 
50 -3.80 -4.50 -0.90 
60 -4.20 -4.50 -0.50 
70 -4.00 -3.00 -0.90 
80 -3.40 0.00 -0.50 
90 -3.20 3.00 -2.90 
 
Patient2: 
CT Phase Sets X movement (mm) Y movement (mm) Z movement (mm) 
Non-gated 0 0 0 
nil 0.80 -1.50 -0.40 
10 0.30 -1.50 0.00 
20 0.50 -3.00 0.00 
30 1.70 -3.00 -0.20 
40 1.70 -3.00 -0.40 
50 1.40 -3.00 -0.70 
60 1.60 -3.00 -0.50 
70 1.30 -3.00 -0.30 
80 1.20 -3.00 -0.50 








CT Phase Sets X movement (mm) Y movement (mm) Z movement (mm) 
Non-gated 0 0 0 
nil 0.70 1.00 0.80 
10 0.10 1.00 0.40 
20 0.80 -1.00 0.40 
30 0.20 0.00 0.20 
40 0.60 0.00 -0.10 
50 -0.20 0.00 0.10 
60 0.90 0.00 -0.10 
70 0.50 0.00 0.30 
80 1.00 0.00 1.10 
90 0.40 0.00 0.40 
 
Patient5: 
CT Phase Sets X movement (mm) Y movement (mm) Z movement (mm) 
Non-gated 0 0 0 
nil 0.00 -1.00 -3.20 
10 -0.70 -1.00 -4.30 
20 -1.00 0.00 -5.00 
30 -1.30 -1.00 -5.40 
40 -0.70 -1.00 -5.20 
50 -1.40 -2.00 -4.10 
60 -0.50 -3.00 -3.30 
70 -0.60 -3.00 -2.70 
80 -0.70 -3.00 -3.00 









Patient6 (1st lesion – Lat Lung): 
CT Phase Sets X movement (mm) Y movement (mm) Z movement (mm) 
Non-gated 0 0 0 
nil -2.10 7.00 -0.80 
10 -1.60 7.00 -0.80 
20 -1.20 1.00 2.40 
30 -2.00 -1.00 2.40 
40 0.00 0.00 0.00 
50 -1.30 -2.00 2.00 
60 -1.50 -1.00 2.60 
70 -0.20 -1.00 0.40 
80 -1.30 0.00 2.70 
90 -2.10 7.00 -0.80 
 
Patient6 (2nd lesion – Med Lung): 
CT Phase Sets X movement (mm) Y movement (mm) Z movement (mm) 
Non-gated 0 0 0 
nil 0.00 4.00 0.10 
10 0.00 4.00 -0.40 
20 0.00 2.00 0.40 
30 0.00 2.00 0.30 
40 0.20 0.00 0.20 
50 0.00 0.00 0.00 
60 0.20 0.00 0.60 
70 0.40 1.00 0.80 
80 0.00 1.00 0.50 

































nil -3.50 -4.00 3.00 3.00 -3.80 -4.00 
10 -2.00 -2.00 3.00 3.00 -4.00 -4.00 
20 -3.10 -3.00 0.00 0.00 -4.00 -4.00 
30 -3.80 -4.00 -3.00 -3.00 -1.50 0.00 
40 -4.00 -4.00 -3.00 -3.00 -1.70 0.00 
50 -3.80 -4.00 -4.50 -5.00 -0.90 0.00 
60 -4.20 -4.00 -4.50 -5.00 -0.50 0.00 
70 -4.00 -4.00 -3.00 -3.00 -0.90 0.00 
80 -3.40 -3.00 0.00 0.00 -0.50 0.00 




























nil 0.80 0.00 -1.50 0.00 -0.40 0.00 
10 0.30 0.00 -1.50 0.00 0.00 0.00 
20 0.50 0.00 -3.00 -3.00 0.00 0.00 
30 1.70 0.00 -3.00 -3.00 -0.20 0.00 
40 1.70 0.00 -3.00 -3.00 -0.40 0.00 
50 1.40 0.00 -3.00 -3.00 -0.70 0.00 
60 1.60 0.00 -3.00 -3.00 -0.50 0.00 
70 1.30 0.00 -3.00 -3.00 -0.30 0.00 
80 1.20 0.00 -3.00 -3.00 -0.50 0.00 






























nil 0.70 0.00 1.00 0.00 0.80 0.00 
10 0.10 0.00 1.00 0.00 0.40 0.00 
20 0.80 0.00 -1.00 0.00 0.40 0.00 
30 0.20 0.00 0.00 0.00 0.20 0.00 
40 0.60 0.00 0.00 0.00 -0.10 0.00 
50 -0.20 0.00 0.00 0.00 0.10 0.00 
60 0.90 0.00 0.00 0.00 -0.10 0.00 
70 0.50 0.00 0.00 0.00 0.30 0.00 
80 1.00 0.00 0.00 0.00 1.10 0.00 




























nil 0.00 0.00 -1.00 0.00 -3.20 -3.00 
10 -0.70 0.00 -1.00 0.00 -4.30 -4.00 
20 -1.00 0.00 0.00 0.00 -5.00 -5.00 
30 -1.30 0.00 -1.00 0.00 -5.40 -5.00 
40 -0.70 0.00 -1.00 0.00 -5.20 -5.00 
50 -1.40 0.00 -2.00 -2.00 -4.10 -4.00 
60 -0.50 0.00 -3.00 -3.00 -3.30 -3.00 
70 -0.60 0.00 -3.00 -3.00 -2.70 -3.00 
80 -0.70 0.00 -3.00 -3.00 -3.00 -3.00 































nil -2.10 -2.00 7.00 7.00 -0.80 0.00 
10 -1.60 0.00 7.00 7.00 -0.80 0.00 
20 -1.20 0.00 1.00 0.00 2.40 2.00 
30 -2.00 -2.00 -1.00 0.00 2.40 2.00 
40 0.00 0.00 0.00 0.00 0.00 0.00 
50 -1.30 0.00 -2.00 -2.00 2.00 2.00 
60 -1.50 0.00 -1.00 0.00 2.60 3.00 
70 -0.20 0.00 -1.00 0.00 0.40 0.00 
80 -1.30 0.00 0.00 0.00 2.70 3.00 
90 -2.10 -2.00 7.00 7.00 -0.80 0.00 
 


























nil 0.00 0.00 4.00 4.00 0.10 0.00 
10 0.00 0.00 4.00 4.00 -0.40 0.00 
20 0.00 0.00 2.00 2.00 0.40 0.00 
30 0.00 0.00 2.00 2.00 0.30 0.00 
40 0.20 0.00 0.00 0.00 0.20 0.00 
50 0.00 0.00 0.00 0.00 0.00 0.00 
60 0.20 0.00 0.00 0.00 0.60 0.00 
70 0.40 0.00 1.00 0.00 0.80 0.00 
80 0.00 0.00 1.00 0.00 0.50 0.00 







Manufacture of the two-piece Plaster of Paris impression: 
Plaster of Paris or Gypsum is a crystalline mineral of hydrated calcium sulphate (chemical 
formula CaSO4 • 2H2O).  Gypsum is colourless or white, is not highly water-soluble and is 
not at all hard.  A mixture of gypsum and water can be poured; the gypsum hardens as the water 
evaporates.  In art gypsum is mainly used in the partly dehydrated form of plaster of Paris 
(2CaSO4 • H2O) to make casts of objects or works of art in sculpture (moulds).  The process 
entails making a negative form, of a sculpture, for instance, which is then coated with plaster 
of Paris.  Plaster of Paris models of sculpture were widespread in antiquity and the practise was 
revived in the Renaissance.  From the late 17th century plaster of Paris casts was made for art 
academy study and model collections (plaster cast collections), which were taken up by 
museums and art historical and other institutes in the 19th century. 
Online search / accessed on 18 March 2019 at 12:20. 
https://www.kettererkunst.com/dict/gypsum-plaster-of-paris.php 
 
The room was prepared, and rolls of Plaster of Paris bandage were cut into 35cm strips or 
lengths.  The subject had to have aqueous cream rubbed on the skin to prevent the plaster from 
sticking onto the skin.  All body hair was covered with a Jelonet material to prevent adhering 
to the plaster. 
 
Jelonet consists of a leno-weave fabric, of cotton or cotton and viscose, which has been 
impregnated with white soft paraffin (yellow soft paraffin in the case of the bulk preparations). 
The dressing is used as a primary wound contact layer and the paraffin is present to reduce the 
adherence of the product to the surface of a granulating wound. 
Online search / accessed on 18 March 2019 at 12:30. 
http://www.dressings.org/Dressings/jelonet.html 
 
Warm water was used, 4 layers of Plaster of Paris bandage was moulded over the skin from the 
superior surface of the neck to lower than the diaphragms on the posterior surface to include 
the side of the chest wall.  Once the plaster bandage was firm, a layer of aqueous cream was 
rubbed around all the edges, which will give access to loosen the posterior and anterior 
impressions from each other.  The anterior impression was made using the same manner as 
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above.  A 2cm overlap on the sides of the chest walls was also made from the neck down to 
the lower diaphragm to ensure a full two-piece impression of the thorax. 
 
When the Plaster of Paris bandage had set, the anterior and posterior impression was removed 
from the subject.  These two halves were then taken to the mould room laboratory.  At each 
end of the neck and lower diaphragm level, it had to be enclosed with Plaster of Paris bandage 
to form a shell so that Plaster of Paris material could be poured into each one of the halves. 
 
A separating medium was coated on the inside of the impression to prevent the Plaster of Paris 
model sticking to the impression bandage.  The models were secured on a levelled surface and 
immobilized in that position. Water was poured into a bowl at 3/4 level and then gradually 
Plaster of Paris powder is sifted into the water until most is absorbed by the water.  The mixture 
is mixed thoroughly using a spatula until a smooth and creamy texture is obtained.  This is then 
poured into the negative Plaster of Paris shell. The process is repeated until the impression is 
filled to the edges.  The second impression was filled in the same manner. 
 
Both positive models are left to set and dry for 2 days as they were very large in size.  The 
outer layers of Plaster of Paris bandage were removed from both models. The positive models 
were then smoothed and filed until perfect as a Vacuum forming technique is used to 
manufacture the Ultra High Impact Acrylic shell. It is important to ensure that the edge of 
overlap of the two-piece model, is carefully maintained so that the two halves will accurately 
fit together, this is to ensure a tight fit when filling the shell with tissue equivalent impression 
material. 
 






Annexure C 1:  Thorax 
 
The customised build thorax and lung moulds were vacuum wrapped with thermoplastic. 
 
Due to a height constraint on the vacuum machine (maximum part height – 250mm) the thorax 
was cut in half (anterior-posterior distance).  This also assisted with an opening that is needed 
in the thorax for the arm to move in and out of the thorax to simulate the motion of the tumour.  
Unfortunately, with the thorax mould the amount that was needed to decrease the fitted height 
into the vacuum press, the shape that was originally designed and the 2cm overlap to fit anterior 
and posterior halves, were lost.  At the time it did not seem to be a problem. 
 
 
Figure Off-cut from thorax mould to fit into vacuum press 
 
The mould had to be flattened otherwise the vacuum press will not be able to ‘couple’ or attach 
between the bed of the press and mould to form a proper vacuum to draw the thermoplastic 
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over the mould.  The mould was clamped down and secured with a piece of wood and screws 
when the brushes run over the bottom of the mould to flatten the surface in preparation of the 
vacuum press to work optimally. 
 
Figure Thorax mould clamped down 
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Figure Mould clamped with screws and a piece of wood 
 
Video Clip Flattening bottom of thorax mould 
 
   




The thorax mould was laid onto the 2900mm vacuum bed. 
 
 
Figure Mould on bed 
The 2mm thermoplastic in jig is placed over the thorax mould in preparation of heating 




Temperature and pressure are PC controlled through the interface of the vacuum press.  The 
technical specification of the machine is for the heaters 45kW and vacuum 65m3/hr. 
 
Figure Settings on vacuum press 
 
   





When the pre-set temperature is achieved, the mould is extracted from underneath the heaters 
and the membrane is fitted over the mould and jig.  This membrane is used in the vacuum 
process as can see below in the photos and video clip. 
   
 
 
Figure (a-c) Membrane fitted over mould and heated thermoplastic 
 
Video clip 3 
 
This process of heating and vacuum is repeated until the desired form or shell is achieved. 
 
Figure Repeat process of heating and vacuum 
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Video clip Temp 
 
   
Figure Finished vacuum wrap thorax 
 
The outer shell comprises of 2mm Perspex sheeting vacuumed wrapped around a mould that 
was reconstructed from the dimensions of the patient’ dataset ribcage printed.   
 
After the plastic shell was cool enough to work with, it was cut from the jig with an overlap to 
secure the two halves. 
 




Figure (a-c) The plastic mould or shell is cut from the jig 
 
Unfortunately, the plaster of paris mould did not want to come loose from the thermoplastic 
and the mould was damaged trying to loosen it from the shell. 
 
     
Figure (a) Mould damaged (b) plastic shell finished 
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It was evident now that trying to fit the two halves, it did not fit anymore as was planned, due 
to the limitation on the vacuum press with the maximum part height of 250mm. 
 
     
 
Due to this misfit of the 2 halves it was impossible to secure for no leakage of the tissue 
equivalent material to be used.  The posterior half of the thorax had to be redone.  The same 
process was followed with the plaster of paris except that no subject was used, but the mould 





Annexure C 2:  Lungs 
 
The MDF lung moulds were fitted in a jig, thermoplastic of 1mm was added and it was heated.  
Thereafter the vacuum process was followed, half settings for temperature and pressure were 
used due to the fact of the thinner and smaller moulds used to fabricate the lung shells. 
 
   
 Figure (a+b) MDF moulds for lung 
    
 

















































Mixing method for Encapso K: 
Two clear liquids (part A and B) are mixed in equal amounts (parts) after vigorously shaking 
to mix each one separately before commencing with the mixing of the two liquids.  Mix for at 
least 5minutes, making sure that all is blended especially against the sides of the container.  
The mixture at first appears to be cloudy but will clear after a few minutes.  Please see 
Addendum D for Specifications and Manual of Encapso K.   
 
   
Figure Mixing equal amounts of Encapso K Part A and B 
 
Due to the viscosity of the liquid, it is important to fixate all parts (ribcage and lungs) in relation 
to the thorax as per anatomy. 
 
The opening was at the inferior part of the thorax; therefore, all organs or parts was suspended 
upside down.  The ribcage was fastened with fishline at multiple points due to the ribcage being 
fragile and not only one point can be used as fixation.  The lung shells were also fixed with 
fishline and could be manoeuvred as with a puppet to have tilt and angle correct in the ribcage.  
For weight support in the ‘liquid’ and that the air lung cavities do not stay afloat, thick wooden 
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sticks were propped inside the cavities to weigh it down when the liquid is poured and curing 
sets in place over a period of at least 16hours or overnight preferably. 
   
 
   
Figure (a-c) Fix thorax shell upside down (d) fish line tied to multiple parts of ribcage 
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Figure (a-d) Ribcage suspended in shell 
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(a)              (b) 
 
Figure (a+b) lung cavities within ribcage hanging upside down (c) Weight bearing down in 




As soon as all the parts were in a satisfactory position according to anatomy of the thorax, the 
pouring process started.  A funnel with a pipe extending into the ‘bottom’ of the thorax shell is 
used to pour the liquid into the body shell.  Unfortunately, as the liquid poured into the shell, 
where the body shell was not sealed properly due to misfit of 2 halves explained earlier, leakage 
was a huge problem.  The pouring process was stopped immediately to first not waste any more 
of the rubber liquid and secondly find a solution to seal all openings. 
 
   
Figure Pouring of Encapso K into thorax shell 
Video clips pouring (2019-03-13-11-48-10+54) 
 
Plaster of paris was wrapped around the thorax shell and plastic tied down ‘tightly’ with tape 
around the plaster of paris.  One part of the mixture was again poured into the thorax shell and 
monitored for more leakage throughout the day.  At the end of the day, curing started to take 
place and the thorax was filled to just under the edge of the lung cavities as these need to stay 
clear of any mixture and only air filled.  Another consideration was to ensure that the ribs are 
as far as possibly enclosed or completely covered with the rubber compound to minimise 
breakage or breaking off of any ribs or part thereof at the inferior part of the ribcage.  Due to 
the position of the lung cavities in relation to the ribcage a small part of the ribcage was left 
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open and not covered by the rubber compound.  Care should be taken when handling the 
phantom. 
 
   
(a)                          (b) 
Figure (a) Plaster of Paris was wrapped around the thorax shell (b) pouring to bottom of lung 
cavities 
 
After overnight curing the phantom was set and the plaster of paris and plastic removed.  The 




   
 
 













0.3mm Calculation grid size was used: 
 
 
Monaco TPS (Version 5.11.02)
Calculation Dose to water
6MV 10MV
10x10 5x5 10x10 5x5
Gy Gy Gy Gy
Perspex 0.919 0.859 0.973 0.917
With only Silicon 0.739 0.667 0.825 0.750
With 3D prints 0.699 0.619 0.781 0.713
embedded
Transmission S 0.8041 0.7765 0.8479 0.8179
Transmission 3D 0.7606 0.7206 0.8027 0.7775




0.25mm Calculation grid size was used: 
 
Monaco TPS (Version 5.11.02)
Calculation Dose to medium
6MV 10MV
10x10 5x5 10x10 5x5
Gy Gy Gy Gy
Perspex 0.900 0.841 0.952 0.898
With only Silicon 0.724 0.653 0.808 0.735
With 3D prints 0.684 0.606 0.764 0.699
embedded
Transmission S 0.8044 0.7765 0.8487 0.8185
Transmission 3D 0.7600 0.7206 0.8025 0.7784
Attenuation coefficient and stopping power ratios are taken as those for in the medium
Eclipse Version 15.6, AAA Algorithm
6MV 10MV
10x10 5x5 10x10 5x5
Gy Gy Gy Gy
Perspex 0.917 0.862 0.962 0.901
With only Silicon 0.769 0.696 0.839 0.762
With 3D prints 0.694 0.621 0.763 0.694
embedded
Transmission S 0.8386 0.8074 0.8721 0.8457
Transmission 3D 0.7568 0.7204 0.7931 0.7703
The Calibration curve of the CT scanner is used to convert the Hounsfield Unit 






Eclipse Version 15.6, Acuros Algorithm
Calculation Dose to water
6MV 10MV
10x10 5x5 10x10 5x5
Gy Gy Gy Gy
Perspex 0.917 0.87 0.962 0.909
With only Silicon 0.775 0.7 0.839 0.767
With 3D prints 0.709 0.637 0.787 0.719
embedded
Transmission S 0.8451 0.8046 0.8721 0.8438
Transmission 3D 0.7732 0.7322 0.8181 0.7910
The Calibration curve of the CT scanner is used to convert the Hounsfield
Unit values to mass density
From the derived mass density, Acuros XB determine the material composition






Eclipse Version 15.6, Acuros Algorithm
Calculation Dose to medium
6MV 10MV
10x10 5x5 10x10 5x5
Gy Gy Gy Gy
Perspex 0.893 0.847 0.943 0.885
With only Silicon 0.758 0.686 0.819 0.745
With 3D prints 0.690 0.621 0.769 0.699
embedded
Transmssion S 0.8488 0.8099 0.8685 0.8418
Transmission 3D 0.7727 0.7332 0.8155 0.7898
The Calibration curve of the CT scanner is used to convert the Hounsfield
Unit values to mass density
From the derived mass density, Acuros XB determine the material composition
of voxels in the image
